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 ABSTRACT 
 
It is well accepted that transcription factors (TFs) play a crucial role in 
determining cell identity. Although RNA expression or protein abundance data show 
that a large fraction of the total TFs are expressed in a given cell, however, only a small 
set of them is essential for specifying cell identity. This was elegantly demonstrated 
through reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) by 
means of ectopic expression of only four key TFs, Oct-3/4 (Pou5f1), Sox2, Klf4 and c-
Myc.  
In order to decipher the most predominant TFs in specific cell types, we 
developed a novel massively parallel protein activity assay, Active TF Identification 
(ATI) that measured DNA-binding activity of TFs in the cell nucleus. This method 
indicated that around 15 TFs have the highest DNA-binding activities, among which 
there are “common” TFs universally active in most cell types, “shared” TFs which are 
active in several cell types and “specific” TFs which are active in only one or two cell 
types.  
It has been well established that the gene transcription is highly correlated with 
disruption of nucleosomes at the gene regulatory elements. In order to test if TFs are the 
major determinant of chromatin accessibility, we compared the ATI data with the 
DNase I hypersensitive sites (DHSs) from the same cell or tissue type, and found out 
that the enriched subsequences in the ATI results are also enriched within the DHSs 
compared with the non-DHS regions. This suggested that the DNA-binding activity of 
TFs, especially the most active ones, played major roles in determining the chromatin 
accessibility. 
In addition, we also performed the ATI assay using nucleosomal DNA to 
determine the “pioneer” TFs in cells that are capable of binding condensed chromatin.  
This study has generated a deeper understanding of the gene regulatory logic 
and helped us to decipher important TFs in specific cell types.  
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1  INTRODUCTION 
 
1.1 TRANSCRIPTION FACTORS 
 
Transcription factors are proteins that can bind specific DNA sequences through 
their DNA-binding domains. It is well established that transcription factors (TFs) play 
crucial roles in determining specific cell identity1-4, and that a large fraction of all TFs 
are actually expressed in most cell types5,6. However, it is still unclear how TFs interact 
with each other as well as other regulators to set up the whole transcriptome profile in a 
given lineage.  
 
1.1.1 Basic features of TFs 
 
In general, there are two types of TFs, the general transcription factors (GTFs) 
and the specific TFs. The GTFs are a group of proteins responsible for recognizing the 
specific sites within the core promoters of transcribed genes and recruiting RNA 
polymerase II to form the pre-initiation complex (PIC) for the initiation of transcription. 
In bacteria, there is only one GTF, the sigma factor7; in eukaryotes, the GTFs include 
six members, namely TFIIA, TFIIB, TFIID, TFIIE, TFIIF, and TFIIH, which work 
together to recruit RNA polymerase II to initiate transcription8. Other TFs, known as 
specific TFs, are capable of interacting with DNA through their DNA binding domains 
(DBDs) with high specificity. The specific TFs usually bind specific regulatory regions 
(including promoters and enhancers) of the genome to induce (or repress) transcription 
of particular genes in different cell types. Compared with the GTFs, the specific TFs 
account for a vast majority of the transcription factors and possess more diverse DNA-
binding specificities. Furthermore, since GTFs are universally expressed in all cell 
types whereas specific TFs are more restricted in their expression, it is therefore 
plausible that specific TFs play more important roles in determining the cell identity 
than the GTFs do. Hereafter, the TFs refer to specific TFs in this thesis. 
The transcription factors interact non-covalently with DNA, mainly through 
hydrogen bonds and Van der Waals forces. The contact between TFs and DNA 
contains both specific and nonspecific interactions. The specific interactions occur 
between the specific TF amino acid residues and the nucleotide bases within the core 
binding sites of the DNA sequences; the nonspecific interactions usually occur between 
the TF and the phosphate backbone of the DNA9. Although the nonspecific interactions 
do not contribute to the binding specificity of TFs, they are actually quantitatively 
significant for TF/ DNA binding10,11.  
Binding specificities of more than 1000 TFs from over 131 species have been 
determined and classified into 54 groups based on their DBDs (Figure 1.1)12, indicating 
that many TFs share DNA binding specificities with similarly structured DBDs. In 
addition, the binding specificities of TFs are conserved among distant species; for 
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instance, almost all Drosophila TFs share similar binding motifs with their mammalian 
orthologous genes13. Another important feature of a TF is its binding affinity with 
DNA. The binding affinity indicates how strong the interaction is between the TF and 
the corresponding DNA sequence, and it varies among different DBDs, and even 
among different members within the same TF family. An estimate of the binding 
affinity is important to understand how TFs target different genomic loci to regulate 
gene expression. As the binding affinity of specific TF to DNA determines the 
equilibrium dissociation constant (Kd) of the interaction between the TF and the DNA 
molecule, it therefore determines the minimum concentration of a TF needed for 
targeting the specific DNA sequence in the genome. Currently we still lack the 
knowledge about binding affinity between different kinds of TFs and DNA sequences.  
 
  
Figure 1.1 Classification of TFs into 54 DBD groups 
All of the studied 1,032 TFs from more than 131 species are classified into 54 groups in total based on the DBD classes. The DBD 
classes or species containing fewer than five members are grouped into “Other”. The species are ordered by the total number of TFs 
with characterized motifs. Note that some TFs have more than one DBD classes, they are therefore classified into independent 
groups, namely the “Homeo+POU” and the “AP2+B3” groups. Figure is adapted from 12.  
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Apart from interacting with the DNA sequences on their own, a TF can also 
interact with particular DNA sequence together with other TFs either through protein-
protein interactions or through conformational changes of DNA14. In most cases, the 
recognition sites of the heterodimer TFs are quite different from each individual TF’s 
binding sites based on our in vitro test14, arising mainly from the overlap between 
individual TF recognition motifs. In some other cases, the dimeric motifs look like 
combination of both motifs, but the flanking space or the orientation of the motifs could 
be quite strict14.  
Because of diverse binding specificities of different types of TFs, the TFs are 
considered to be the core apparatus for specificity in gene regulation. They are 
responsible for recruiting other types of transcriptional regulators as well as RNA 
polymerase to the right positions of the genome, leading to the repression or induction 
of target gene expression. By providing specificity to gene regulation, TFs are thus 
essential in determining the cell identity. Ectopic expression of specific TFs can alter 
cellular identity. For instance, the epigenome and transcriptome of mouse fibroblast can 
be reprogrammed into that of the induced pluripotent stem cell (iPSCs), a cell type 
similar to the embryonic stem (ES) cell, by overexpressing a small set of TFs (Figure 
1.2)3,15,16. The fibroblasts can also be directly converted to muscle cells by introducing 
only one TF, MyoD2. Therefore, introduction of a small set of TFs is sufficient to 
change the cell fate, indicating that the core transcriptional regulatory network 
responsible for establishing the whole transcriptional program for a particular cell 
identity is mainly composed of a small set of TFs.  
 
Figure 1.2 Induction of pluripotent stem cells by introducing TFs 
The somatic cells are reprogrammed to the ES cell-like induced pluripotent stem cells (iPSCs) through introducing four TFs (Oct4, 
Sox2, Klf4 and c-Myc), which have been shown to play important roles in maintaining pluripotency of the ES cells. Figure is adapted 
from 17. 
 
 
1.1.2 Post-translational modifications of TFs 
 
Like other kinds of proteins, such as enzymes, the TFs are also subject to post-
translational modifications, resulting in changes in either their activities or cellular 
locations or interactions with other proteins. In the past few years, it has become 
apparent that different types of post-translational modifications, such as 
phosphorylation, ubiquitination, sumoylation and acetylation affect various aspects of 
TF functionality. The influence of these modifications is highly dependent on the 
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protein sequence of TFs, and adds an additional layer of complexity in regulation of 
gene expression by TFs.  
Protein phosphorylation and dephosphorylation are carried out by protein 
kinases and phosphatases, respectively that are usually activated by multiple 
extracellular signaling pathways. Phosphorylation of TFs regulates their functions 
through different mechanisms: for instance by controlling the localization of the TFs, 
by modulating interactions with other factors, and by regulating binding activity with 
DNA. For instance, the SMAD family TFs, SMAD2 and SMAD3 are activated by the 
members of the transforming growth factor-β (TGF-β) family cytokines, leading to the 
phosphorylation of the serine residues at the carboxyl end of SMAD proteins18. The 
phosphorylated SMAD proteins can then associate with the common SMAD binding 
partner SMAD4 and be translocated to the nucleus to regulate gene expression. In 
contrast, the DNA binding activity of bZIP family TF c-JUN is inhibited when the 
COOH-terminal residues (threonine 231, serine 243 and serine 249) are 
phosphorylated19. Phosphorylation of its NH2-terminal transactivation domain on the 
other hand causes conformational change and dephosphorylation of the COOH-terminal 
residues, leading to increased DNA binding19,20.  
Ubiquitination is a process of addition of ubiquitin, a 76 amino acid peptide to 
the substrate proteins. The ubiquitination of proteins is usually associated with protein 
degradation via proteasome21, but in recent years emerging data from yeast has revealed 
that ubiquitination can also regulate TF activity in a proteolysis-independent manner. 
For example, Kaiser et al. have demonstrated that in the yeast ubiquitination of TF 
MET4 lead to inactivation rather than degradation of the protein22. Moreover, the 
monoubiquitination of TF GAL4 was reported to stabilize transcription factor-DNA 
interactions in yeast23. However, regulation of TF activity through ubiquitination of 
proteins in proteolysis-independent way has not been detected in the mammalian cells.  
Sumoylation refers to covalent attachment of SUMO, a small polypeptide, to 
the lysine residues of the substrate proteins24,25. Although not well studied yet, it has 
been shown to affect TF activity, stability and localization. The activities of TFs such as 
SP326, MYB27 and CEBP28 family TFs are all influenced by the SUMO-modification. 
Furthermore, because the lysine residues of proteins can also be post-translationally 
modified by phosphorylation, ubiquitination and acetylation, sumoylation can alter the 
transcription factor activities by competing with other types of modifications at the 
target lysines. For example sumoylation of the IκBα- the inhibitor of TF NF-κB at 
lysine residues K21 can stabilize the IκBα protein by blocking ubiquitination of the 
same residue, leading to inhibition of NF-κB activity29.  
The protein acetylation is controlled by two types of enzymes, lysine 
acetyltransferases (KATs) responsible for transferring the acetyl groups to lysine 
residues of the proteins and lysine deacetylases (KDACs) responsible for removing the 
acetyl groups from the acetylated lysine residues30. Different kinds of TFs are subject to 
acetylation, leading to their activation/inactivation or changes in their cellular 
localization. For instance, acetylation of the three lysine residues (Lys-242, Lys-245, 
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and Lys-262) within the DNA-binding domain of FOXO1 TF diminishes its ability to 
interact with DNA31,32, whereas the lysine residues (Lys-91, Lys-94, and Lys-136) 
located within the transactivation domain of TF CREB when acetylated by CBP/p300, 
leads to increased transactivation activity33. In most cases, acetylation of lysine residues 
within the DNA-binding domains of TFs attenuates the interactions between TFs and 
DNA. However, there is one exception, acetylation of lysine residues within the DBD 
of GATA1 by CBP/p300 leads to enhanced DNA binding activity both in vitro and in 
vivo34.  
In addition to the above mentioned modifications, the TFs are also subject to 
other types of modifications including methylation and glycosylation. Methylation 
usually occurs at the arginine and lysine residues of the TFs, and the deregulation of TF 
methylation is frequently linked with diseases such as cancer35,36. The addition of O-
linked beta-N-acetylglucosamine (O-GlcNAc) to the serine or threonine residues leads 
to the glycosylation of TFs. O-GlcNAc modification modulates functions of TFs in 
different ways, such as affecting their DNA-binding activities, localization and 
stability36,37.  
 
  
Figure 1.3 Types of post-translational modifications on TFs 
The six major post-translational modifications occur on the TFs. They can be divided into two groups according to the atoms that are 
modified: the “O-linked modifications” including phosphorylation and glycosylation affect the oxygen atoms of the proteins,; the “N-
linked modifications” including methylation, acetylation, sumoylation and ubiquitination affect the nitrogen atoms of the proteins,. 
Figure is adapted from 36.  
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In summary, the activity of TFs is highly dependent on the post-translational 
modifications that change the cellular localization, DNA binding activity, and 
transactivation activity of TFs. Therefore, it is quite important to measure the binding 
activity, rather than only the abundance of TFs in the cell nucleus to understand the 
mechanism of transcriptional regulation more thoroughly.    
 
1.1.3 Technologies to study binding specificities of TFs 
 
There are a variety of technologies utilized to study the TF binding with DNA 
both in vivo and in vitro. The in vivo methodology focuses on the interactions between 
the proteins and genomic DNA in cells; the in vitro methodology studies the 
interactions between the proteins and the in vitro synthetized DNA molecules. 
Compared with the in vivo assays, the in vitro assays are performed in simplified 
systems without the interference from other nuclear components. On the other hand, the 
results from in vivo assays represent the combined effect of variability in both the TF 
features as well as the DNA features. In different cell types or even in different loci of 
the genome from the same cell type, the status of the DNA with respect to its 
modification and TF accessibility is quite variable. Moreover, the interactions between 
TFs and DNA in vivo are also influenced by other factors such as non-coding RNA. 
Thus, the in vivo methodology to study TF binding is advantageous as this combined 
information is directly related to the binding events happening in cells, which is crucial 
for us to understand the mechanism of transcriptional regulation in cells.  
The typical in vivo method to study TF binding in the genome is the chromatin 
immunoprecipitation (ChIP) assay, where the proteins bound to the genome are first 
covalently cross-linked to the DNA, followed by fragmentation of the chromatin and 
purification of desired proteins as well as cross-linked DNA fragments using specific 
antibodies38. The ChIP assay has been instrumental in identifying the interactions 
between DNA fragments from specific genomic regions and a wide range of nuclear 
proteins including TFs, modified histones, and chromatin remodelers. Moreover, ChIP 
assay followed by high-throughput sequencing technologies has further extended the 
scope of these experiments to genome-wide identification of TF binding locations38,39, 
resulting in thousands to millions of binding sites identified throughout the genome. 
The TF binding specificity can potentially be determined by analyzing the genome-
wide binding sites with the help of various kinds of computational algorithms such as 
MEME40, Weeder41, MDScan42, and WebMOTIFS43. However, de novo motif 
discovery based on the ChIP-seq data for different TFs has indicated that it does not 
work so well for most TFs, partially because the DNA fragments pulled down together 
with the tested TFs are one or two order of magnitudes larger than a typical motif 
resulting in inherent noise. In order to identify the TF binding sites at a higher 
resolution, different groups have modified the ChIP technology and established novel 
technologies such as ChIP-exo44,45 and ChIP-nexus46 to achieve higher resolution. Both 
of these methods utilize the lambda exonuclease to degrade the protein-bound DNA in 
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a 5’-to-3’ direction until it is blocked by the cross-linked proteins, leading to the 
enrichment of precise genomic loci bound by the TFs.  
Compared with the in vivo assays, the in vitro assays originated much earlier 
and are usually applied to study the TF binding specificities de novo. DNA footprinting 
is one of the classical techniques to examine the binding of proteins to specific DNA 
sequences. It exploits the fact that when a TF is bound to DNA with a certain affinity, 
the DNA is then protected from degradation by nucleases. After digestion with 
nucleases, the bound and unbound DNA oligos can be separated on a polyacrylamide 
gel47,48. The nitrocellulose filter binding assay, developed in the early years of 
molecular biology, is another classical method to study the protein-DNA interactions. 
This assay relies on the specific chemical property of the nitrocellulose membrane to 
retain the proteins together with the bound DNA oligos and at the same time have quite 
low binding affinity with the free double-stranded DNA49-51. This is used to enrich and 
analyze the double-stranded DNA bound by the proteins. In comparison to these two 
assays described above, the electrophoretic mobility shift assay (EMSA) is a technically 
simple and relatively rapid method to detect protein-DNA interactions. The principle of 
this method is that the electrophoretic mobility of a complex composed of nucleic acid 
and protein is less than that of the free nucleic acid, resulting in the separation of bound 
and unbound DNA ligands52-54. Moreover, the EMSA assay can not only be utilized for 
qualitative purposes, but also provide quantitative information for determining binding 
affinities and kinetics55. 
Development of advanced technologies such as the microarray-based techniques 
and the massively parallel sequencing techniques have led scientists to combine these 
with the traditional methodologies to determine the TF binding specificity in a high 
throughput way. The protein binding microarrays (PBMs) introduced the use of DNA 
microarray technology to study the interactions between individual TFs and DNA 
(Figure 1.4a)56-60. The DNA microarray contains millions of double-stranded DNA 
oligos that have all the potential binding sites for all the TFs tested. The sequences of 
the DNA oligos either originate from the genome59 or are completely randomized58. 
After incubating the microarray with tested protein carrying an epitope tag, the PBM is 
washed to remove any nonspecifically bound protein and then labeled with a 
fluorophore-conjugated antibody specific for the epitope tag; the fluorescence intensity 
for each individual spot on the microarray represents the binding affinity of the specific 
DNA sequence to the tested protein. Additionally, the protein microarray technology 
has also been utilized to identify the interactions among various proteins that recognize 
a particular sequence of interest, expanding our knowledge about protein-DNA 
interactions61-63. Apart from the microarray based technologies, another strategy used 
for studying protein-DNA interactions is the yeast one-hybrid (Y1H) system64,65, which 
is conceptually similar to the classical yeast two-hybrid (Y2H) system used for 
detecting protein-protein interactions in vivo66,67. In the Y1H system, a DNA sequence 
(the DNA bait) is cloned upstream of a reporter gene and integrated into the yeast 
genome; meanwhile, the hybrid protein is generated by fusion of the prey protein to a 
transcription activation domain (Figure 1.4b). The expression level of the reporter gene 
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in the yeast cell can reveal how strongly the prey protein interacts with the DNA bait. 
By generating libraries of DNA constructs with the Gateway cloning system, the 
throughput of the study can be greatly enhanced64. A similar system but based on 
bacteria rather than yeast has also been established to study the DNA-binding 
specificities of Homeobox TFs68.  
The systematic evolution of ligands by exponential enrichment (SELEX) 
technology was first introduced in 1990 to detect specific RNA ligands that have the 
highest binding affinity to the bacteriophage T4 DNA Polymerase from a population of 
RNA ligands with random sequences69. The mechanism of the SELEX technology is 
similar with the process of evolution: during multiple rounds of enrichment, the best 
binding ligands are selected from a variety of random sequences, resulting in the 
exponential increase of the selected ligands. The SELEX protocol was also applied to 
study the binding specificity of TF Lrp to DNA sequences70. Later on, original work 
from our lab significantly increased the throughput of the SELEX assay by utilizing the 
automation system in the SELEX assay and combining it with the massively parallel 
sequencing system.  The resulting high-throughput SELEX (HT-SELEX) assay can be 
performed within a week and characterizes, in parallel, binding specificities of hundreds 
of TFs (Figure 1.4c)71,72. In the HT-SELEX assay, the TFs are expressed in the bacteria 
with a specific epitope tag and purified in 96-well or 384-well plate format. With the 
help of the automation system, the TFs are incubated with double-stranded DNA 
composed of random sequences in the middle and the amplification adapters on both 
ends, following by washing for dozens of times and then purified together with the 
DNA still bound to the proteins; the enriched DNA is directly amplified by polymerase 
chain reaction (PCR) and used as a new DNA pool for another round of selection; 
finally, after several cycles of enrichment, the DNA ligands with the highest binding 
affinity for a particular TF are most selected and become dominating in the population 
of DNA pool. The HT-SELEX assay allows for systematic study of TFs binding 
specificities, and by means of this technology, we have applied the assay to more 
complicated studies, such as effect of TFs dimerization on interacting with DNA14, and 
the systematic studies on interactions between TFs and methylated DNA73.  
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Figure 1.4 High-throughput technologies to study the TF binding specificity 
a) Schematic of the PBM experiment. The double stranded DNA (dsDNA) microarray containing all the potential binding sites for 
all TFs tested is incubated with particular tested TFs carrying an epitope tag (GST), followed by washing and labeling with 
fluorophore-conjugated antibody targeting the epitope tag. After normalizing to the control microarrays, the fluorescence intensity 
for each spot reveals the binding affinity of the tested TF to the DNA sequence. To normalize the signals in each spot, a separate 
microarray from the same print is probed with SybrGreen I. Figure is adapted from 60. 
b) Schematic of the Y1H assay through mating and transformation. prom indicates the promoter, also known as the DNA bait; the 
AD is the Gal4 transcription activation domain; TF indicates the tested transcription factor. The HIS3 and the LacZ are two 
independent reporter genes, reflecting the ability of the yeast to overcome 3AT inhibition and/or turn blue, respectively. If both 
phenotypes are observed in one cell, it means that the interaction between TF and DNA bait is very strong. Figure is adapted from 65.  
c) Schematic of the SELEX assay followed by massively parallel sequencing. A dsDNA pool with randomized sequences is 
incubated with the immobilized TF; after stringent washing process, the DNA ligands still bound to the specific TF are eluted and 
amplified; the amplified DNA are further used for selection during several cycles followed by sequencing. Figure is adapted from 72.  
dsDNA microarrays
Bind epitope-tagged TF
to dsDNA microarrays
Label with fluorophore-tagged
antibody to epitope
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microarrays
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1.1.4 Structured transcriptional regulatory network 
  
Similar with other real-world complex systems we are familiar with, such as the 
World Wide Web (WWW)74,75, the transcriptional regulatory network is interpreted as a 
scale-free network with hierarchical organization76. As a standard scale-free network, 
the basic feature is that the degree distribution of the network follows a power-law, 
where the probability P(k) that a node in the network interacts with k other nodes 
decays as a power law(P(k) ~ k−γ)77, indicating that the network contains numerous 
nodes with only a few links and a small number of nodes with a huge amount of links. 
Those nodes with a huge amount of links are the hubs of the network, and establish the 
core of the whole network. As for the transcriptional regulatory network, thousands of 
TFs are expressed in the cells, but only a small number of them act as the hubs to play 
dominant roles to interact with other TFs and cofactors to set up the transcriptome 
profile for the specific cell identity; these dominant TFs are considered as the master 
regulators of the cell fate.  
In addition, the scale-free networks have several other properties. Firstly, it can 
be freely expanded, indicating that new TFs can be easily supplemented to the existing 
transcriptional regulatory network. This is a very important feature as it speeds up the 
process of evolution by efficiently adding new factors to the original network. Another 
important property is called “preferential attachment”, meaning that every new node 
would preferably connect with already well-connected nodes, the hubs. Therefore, it is 
likely that the most important TFs (hubs) of the network remain the hubs of the network 
in new species during evolution, resulting in the conservation of core transcriptional 
regulatory network during evolution. More importantly, the scale-free network is 
especially robust against accidental failures, which makes the organisms much more 
adaptive to different kinds of perturbations from the environment, and also makes the 
developmental program of multicellular organisms to be smoothly executed under 
fluctuating conditions.  
Apart from that, the hierarchical structure of the network indicates that the 
network can be divided into different groups that can be further subdivided into smaller 
groups over multiple scales78, implying that different types of factors including TFs are 
clustered into different groups to regulate gene expression hierarchically. 
All in all, properties of the transcriptional regulatory network indicate that a 
small number of TFs act at the highest hierarchy to regulate gene expression for specific 
cell identity. Therefore, in order to understand the mechanism of transcriptional 
regulation in different types of cells, it is crucial to first determine the core TFs 
responsible for a particular cell identity. These TFs are expected to possess the highest 
binding activity on the genome in a given cell type to recruit relevant cofactors in order 
to induce or repress gene expression.  
There was no method to detect the DNA-binding activities of all TFs inside the 
cells systematically. Existing technologies such as RNA-seq or proteomics only analyze 
the RNA or protein levels5,6; the ChIP-seq technique does measure the TF activities to 
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some extent, but it cannot compare activity levels between different TFs owing to the 
diverse binding affinities of antibodies to specific TFs71,79,80. In order to measure the 
DNA-binding activities of TFs systematically and identify the most active ones, in this 
project we aimed at establishing a novel massively parallel protein activity assay to 
measure the DNA-binding activity of all TFs from cell extract. 
 
 
1.2 NUCLEOSOME OCCUPANCY & CHROMATIN ACCESSIBILITY 
 
One of the most important features of eukaryotic genome is packaging of DNA 
into nucleosomes and chromatin. The nucleosome is the fundamental unit of chromatin, 
and is composed of a histone octamer core spiraled around by about 147 base pair (bp) 
double stranded DNA (Figure 1.5a)81,82.The nucleosomes are arranged as a linear array 
along the DNA polymer like “beads on a string” (Figure 1.5b)83,84. The formation of 
nucleosomes not only allows the genome to be folded into chromatin and compacted by 
thousands of times to fit in the tiny nucleus, but also sharply increase the complexity of 
gene regulation in eukaryotes compared with the prokaryotes. The occupancy of 
nucleosomes in the genome is closely related to gene expression for specific cell 
identity, as the accessibility of the regulatory elements is directly related to gene 
transcription85.  
 
Figure 1.5 Nucleosome core particle (NCP) octamer 
a) The typical crystal structure of a human nucleosome core particle (NCP). The arrow above the upper ribbon model indicates a 
pseudo 2-fold axis passing through the center of the particle; the bottom figure shows the axial view of the particle. In the core of the 
model, different histones are shown in different colors: yellow for H2A, red for H2B, blue for H3 and green for H4. The brown and 
green ribbon traces around the core histones display the phosphodiester backbones of the DNA for both chains. The Mn2+ and Cl− are 
depicted as cyan and silver balls, respectively. Figure is adapted from 81. 
b) The electron micrograph of chromatin under low ionic-strength solution. The two arrows indicate two nucleosomes along the 
DNA polymer like the “beads on a string”. Scale bar, 30 nm. Figure is adapted from 84. 
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1.2.1 Nucleosome occupancy regulates transcription 
 
The occupancy of nucleosomes regulates transcription in different ways. The 
most direct way is to inhibit transcription initiation by blocking the assembly of 
transcriptional machinery in the core promoters. It has been proved that the presence of 
nucleosomes impedes transcription in vitro86,87, and the nucleosome loss is able to 
expedite the transcription initiation in vivo88,89. Genome-wide mapping of nucleosome 
positioning in species from yeast90-92 to humans93,94 has indicated that active promoters 
are depleted of nucleosomes, restricting the assembly of PIC to specific genomic 
regions for expression of particular genes. Moreover, the positioning of nucleosomes in 
the genome also allows for direct entry of transcriptional machinery to the promoter 
rather than the middle of the gene, which significantly decreases the transcriptional 
noise.  
In addition to blocking the assembly of transcriptional machinery to initiate 
transcription, the nucleosome occupancy also prevents other DNA binding factors, such 
as TFs from binding to the genomic DNA. For instance, Yuan and colleagues have 
shown that most loci (over 87%) bound by TFs were within nucleosome-free regions in 
the budding yeast95, implying that the interactions between TFs and genomic DNA are 
usually blocked by nucleosomes. Based on this phenomenon, a “site exposure” model 
was also proposed to elucidate the competition between TFs and histones on binding 
the genomic DNA, assuming that DNA on the surface of nucleosomes is transiently 
exposed due to thermal fluctuation96,97. Furthermore, original work from our lab 
provided more direct evidence that almost all TFs’ binding events with DNA were 
blocked by nucleosomes98. 
Moreover, the occupancy of genomic DNA by nucleosomes can also facilitate 
access of epigenetic modifiers to the targeted regions to modify the DNA or histones, 
leading to condensation of the chromatin and repression of gene expression. For 
example, the DNA methylation at the regulatory elements is well known to be closely 
correlated with gene repression99-101, and it has been indicated that the de novo DNA 
Methyltransferases DNMT3A/3B are selectively anchored to a subset of nucleosomal 
DNA, which only requires the intact nucleosomal structure rather than the presence of 
other chromatin-modifying enzymes or proteins for their recruitment102.   
Because the nucleosome occupancy regulates binding of transcriptional 
machinery as well as other DNA binding factors, it is expected to play the causal role in 
determining transcriptome profiles in specific cell identity. 
In addition to regulating gene expression, the occupancy of nucleosomes in the 
genome also plays a critical role in other kinds of DNA related processes, such as DNA 
replication and DNA repair103-105. Generally, all these processes need the proteins to get 
access to the genomic DNA, therefore packaging of genomic DNA into chromatin 
inhibits the DNA-dependent processes. Although DNA replication and repair are not 
directly related to the transcription of genes, they also have effect on the cell identity by 
altering the cell cycle length106 or mutating the crucial genes or regulatory elements.  
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1.2.2 Technologies to study chromatin accessibility 
 
It is clear that chromatin accessibility is very important for gene expression and 
cell fate determination. Therefore, identification of the accessible genomic regions in 
specific cell identity is necessary for us to understand the mechanism of cell fate 
determination. In combination with massively parallel sequencing technologies, 
different types of methods have been utilized to determine the genome-wide chromatin 
accessibility in particular cell or tissue types. One classical method is to use low 
concentration of nuclease enzyme Dnase I to cleave the genomic regions that are 
depleted of nucleosomes (Figure 1.6); the DNase I is so active that high concentration 
of the enzyme can even digest DNA exposed in the nucleosome when wrapping around 
histones107. The regions with preferential digestion of DNase I are referred to as DNase 
I hypersensitive sites (DHSs), including all the active cis-regulatory elements, such as 
enhancers and promoters, which are important for regulation of particular genes108-111. 
Furthermore, because the binding of TFs affects the intensity of DNase I cleavage and 
generates footprints of the TFs in the genome, the DHSs can also be applied to study 
the TF occupancy in a qualitative and quantitative manner112.  Apart from DNase I, 
other types of nucleases are also used to study the DNA accessibility. One of the most 
commonly used one is the micrococcal nuclease (MNase), which is an endo-
exonuclease that preferentially digests single-stranded nucleic acids and also has 
activity against double-stranded DNA. The activity of MNase is weaker than the DNase 
I as digestion by MNase can be obstructed by not only nucleosomes, but also other 
types of DNA binding proteins, therefore some DHSs bound by factors such as TFs are 
excluded from digestion by MNase (Figure 1.6). Owing to its weak activity, MNase 
has been applied to other studies beyond the nucleosome analysis. For example, paired-
end MNase-seq has been used to map the distribution of paused RNA polymerase II in 
Drosophila S2 cells113; in addition, the MNase digestion was also conjugated with the 
ChIP technology to identify the binding sites of chromatin structure remodeling (RSC) 
complex in yeast114.  
Apart from nuclease digestion, the accessible genomic regions can also be 
detected with the formaldehyde-assisted isolation of regulatory elements (FAIRE) 
technology, which entails formaldehyde fixation of chromatin and subsequent 
separation of protein-free DNA by phenol–chloroform extraction115. Compared with the 
nuclease digestion, the FAIRE technology does not require the isolation of nuclei, and it 
overcomes the cleavage bias caused by the nucleases116-118. However, there appears one 
major limitation of FAIRE that outweighs all the benefits: the signal-to-noise ratio is 
relatively lower than other chromatin accessibility assays so that only strong signals 
could be informative (Figure 1.6).  
More recently, a novel technology named ATAC-seq (Assay for Transposase-
Accessible Chromatin using sequencing) has been introduced to study chromatin 
accessibility in quite rare biological samples. The principle of the technique is to 
fragment and amplify genomic DNA within the open chromatin regions by using the 
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hyperactive Tn5 transposase loaded with sequencing adapters and proceed to next 
generation sequencing119. The ATAC-seq technique is quite sensitive as in order to get 
similar results from ATAC-seq data, three to five orders of magnitude more cells are 
required in DNase-seq119. Besides, since there is no size-selection step in the ATAC-seq 
protocol, it can also be applied to identify nucleosome positioning and the accessible 
regions simultaneously based on the size of the amplicons, as only sequences longer 
than 147 bp are occupied by nucleosomes, and sequences shorter than 147 bp are from 
accessible regions. Because of the high sensitivity, the ATAC-seq was further utilized 
to study chromatin accessibility in individual cells120, revealing great potential of this 
highly attractive technology in the single cell studies.  
 
 
 
 
Figure 1.6 Schematic diagram of current technologies for studying chromatin accessibility 
Different technologies to study chromatin accessibility are displayed and compared by taking one genomic region as example. The 
colored arrows indicate the boundary of the DNA extracted from different techniques; the colors of the arrows represent different 
techniques, which are the same as those shown in the histograms below. The histograms indicate data signals obtained from each 
assay across the entire region. Figure is modified from 121.  
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1.2.3 Determinants of chromatin accessibility 
 
Since the chromatin landscape of the genome determines the transcriptome 
profile for specific cell identity, we need to find out the determinants of chromatin 
accessibility in order to decipher the determinants of gene regulation. Overall, the 
chromatin accessibility is generally determined by DNA sequences (cis-acting factors) 
and by epigenetic regulators such as chromatin remodelers, transcription factors as well 
as the epigenetic modifiers (trans-acting factors).  
Sequence features. Although the histone octamer has much lower sequence 
binding preference than the sequence specific TFs, the flexibility of DNA sequences 
plays an important role in interacting with the histone octamers as the energy required 
to bend different DNA sequences to wrap around a small octamer of proteins varies a 
lot, resulting in variation in the stability of the formed nucleosomes122. Unlike the 
binding motifs for different types of TFs, there are favorable and unfavorable binding 
patterns resulting from the local bendability of the sequence for nucleosomes to bind to 
the DNA. For example, the poly-dA stretches which are intrinsically stiff and 
superabundant in the eukaryotic genomes relative to the prokaryotic genomes123 have 
been shown to disfavor nucleosome formation both in vitro124-126 and in vivo95,126,127. 
Conversely, the periodic A/T dinucleotides (AA, TT or TA) spaced at 10 bp intervals 
reveal higher binding affinity for histone octamer than random sequences; this pattern 
has also been observed with statistically high significance in different eukaryotic 
genomes128-130.  
Moreover, the importance of sequence features in determining chromatin 
accessibility has also been proved by predicting nucleosome positioning throughout the 
yeast genome with quite high accuracy based only on the data from in vitro 
reconstitution of genomic DNA into histone octamers92. In addition to the yeast, 
genome-wide analyses from higher multicellular organisms such as flies128,131 and 
humans132 also demonstrate that the sequence information of DNA plays important 
roles in determining the chromatin accessibility. However, the power for predicting the 
nucleosome positioning in flies128,132 and humans94,132 is much lower than that in the 
yeast, implying that apart from the sequence features, trans-acting factors, such as 
chromatin remodelers, TFs, and epigenetic enzymes play more important roles in 
setting up the whole genome accessibility in those species.  
It should be noted that because in the multicellular organisms, all cells share the 
same genetic background, meaning that the sequence features of the genome are 
identical for different cell identities, the cell specific chromatin landscape is thus 
determined by the trans-acting factors.  
Trans-acting factors. The trans-acting factors, including TFs, epigenetic 
modifiers, and chromatin remodelers, act as another major determinant of chromatin 
accessibility.  
As mentioned earlier, TFs usually compete with nucleosomes to interact with 
DNA, leading to the ejection of histones out of the DNA at specific loci or vice versa: 
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nucleosomes prevent TF binding. However, in rare cases, the TFs can also promote 
nucleosome assembly via their intrinsic nucleosome-assembly activities133 or by 
recruiting other factors such as polycomb repressive complex 2 (PRC2) to specific 
regions134.  
The epigenetic modifiers are proteins responsible for epigenetic changes, 
including modifications of DNA and histones. In eukaryotes, DNA modifications 
mainly include methylation and demethylation on the 5th carbon atom of the DNA base 
cytosine135, as well as the intermediate of these two major states, such as 
hydroxymethylation136. Nowadays, only the methylation on 5th carbon atom of cytosine 
(5mC) is considered to be heritable and involved in transcriptional regulation; the 
functions of the other intermediate modifications are still unclear. Methylation of 
cytosine is catalyzed by the DNA methyltransferases (DNMTs). In vertebrates, there 
are four members of the DNMTs family, including DNMT1, DNMT3A, DNMT3B and 
DNMT3L. DNMT3L almost has no intrinsic enzymatic activity because of the lack of 
most of the C-terminal catalytic domain compared to other members137. The other three 
DNMTs are the active methyltransferases responsible for the methylation patterns of 
DNA throughout the genome. DNMT1 is essential for the maintenance of the DNA 
methylation during DNA replication138, and DNMT3A/3B serve as de novo DNA 
methyltransferases139. As mentioned earlier, DNA methylation is highly associated with 
gene repression. One of the reasons is that the methylated cytosine would promote 
formation of heterochromatin, leading to the condensation of the chromatin140,141.   
Demethylation of cytosine occurs in vertebrates in two different ways: the 
passive and the active way. In the passive way, methylated DNA is diluted by 
successive DNA replication without maintenance of the methylation pattern through 
DNMT1; for example, during the second and third cell cycle after fertilization, the 
mouse maternal genome is gradually demethylated owing to the loss of DNMT1 
activity142. In addition, the ten-eleven translocation (TET) proteins discovered in almost 
all the metazoans are responsible for the active demethylation of cytosine by oxidizing 
the methyl group to hydroxymethyl group143,144. It is still questionable whether 
hydroxymethylation of cytosine (5hmC) has any regulatory role in gene expression, but 
steadily increasing evidence shows enrichment of 5hmC at specific genomic regions in 
particular cell types, including the ES cells145,146 and neurons in the central nervous 
system147.  
Histone residues, especially the tails, are subject to more than 100 different 
posttranslational modifications, including methylation, acetylation, and 
phosphorylation; some of these modifications have shown significant correlation with 
the chromatin accessibility and transcriptional processes. For example, high level of 
histone 3 lysine 4 trimethylation (H3K4me3) around the transcription start site and 
histone 3 lysine 36 trimethylation (H3K36me3) at the 3’ open reading frame (ORF) 
indicate active transcription of genes148,149; enrichment of acetylation of H3 lysine 9 
(H3K9ac) at the promoter or other regulatory regions displays accessible chromatins 
and gene activation150; whereas methylation of H3 lysine 9 (H3K9me) is closely 
  17 
associated with heterochromatin formation151,152 and DNA methylation153,154, which 
leads to transcriptional repression.  
Because of the close correlation between the epigenetic modifications and 
chromatin accessibility, the epigenetic enzymes responsible for these modifications 
play important roles in determining the chromatin accessibility. Apart from that, some 
epigenetic modifiers are even exclusively expressed in particular cell types, suggesting 
the essential roles of these factors in the specific cell types. For example, the DNA 
demethylase Tet3 is specifically expressed in mouse zygotes and oocytes155,156, 
implying the crucial roles of Tet3 in specification of mammalian gametes; decreased 
expression and enzymatic activities of Tet family proteins, which lead to 
hypermethylation of genomic DNA, also play important roles in development of 
cancers, such as acute myeloid leukemia157 and melanoma158. In addition, many histone 
modifiers are also expressed only in certain cell types, suggesting the importance of 
those factors in cell fate determination. For example H3K36 demethylase Kdm2b159, 
and the common component of the H3K4 methyltransferase complex Wdr5160 are 
specifically expressed in ES cells. Moreover, these histone modifiers are able to 
enhance the efficiency of somatic cell reprogramming to the iPSCs with the help of 
other factors160,161, indicating the crucial roles they play in maintaining pluripotency of 
the ES cells.  
Chromatin remodelers are usually recruited by TFs or modified histone residues 
at specific loci and utilize the energy generated from ATP hydrolysis to change the 
nucleosomes’ architecture through incorporating or ejecting histone octamers, sliding 
nucleosomes and altering nucleosome composition by histone exchange. The chromatin 
remodelers are composed of several subunits, and each subunit has distinct functions 
with respect to the remodeling of chromatin structure. Each chromatin-remodeling 
complex contains one ATPase subunit in addition to other regulatory factors mediating 
protein-protein interactions and protein-chromatin interactions162,163. According to the 
unique domains included in the ATPase subunit, the chromatin remodelers are divided 
into four families: SWI/SNF (switch/sucrose non-fermentable), CHD (chromodomain-
helicase DNA-binding), ISWI (imitation switch), and INO80 (inositol-requiring 
80)162,163. The mechanism of how different chromatin remodelers cooperate with 
histone modifications as well as other transcriptional regulators to alter the chromatin 
architecture is not clearly elucidated. Recently, researchers have determined the binding 
of remodelers to individual nucleosomes in the yeast genome in a high-throughput way, 
and found that different remodelers exhibit distinct and clear distributions with respect 
to transcribed genes164, indicating key roles of these remodelers in transcriptional 
regulation. Furthermore, there is clear evidence showing that the sequence-specific TFs 
play crucial roles in targeting the chromatin remodelers (the ISWI family complex) to 
specific genomic loci, leading to the disruption of nucleosomes in those regions165. 
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Figure 1.7 Classification of chromatin remodelers by the ATPase subunit 
All the chromatin remodelers are categorized into four groups based on different types of domains included in the ATPase subunit. 
The DExx (purple) and HELICc (pink) are the two basic components of the ATPase domain. The INO80 family is distinguished 
from the other three families as it contains a long insertion (white) inside the HELICc domain. Other chromatin remodelers are 
further divided by distinct combinations of flanking domains: Bromo domain (light blue) and HSA (helicase-SANT) domain (red) 
for SWI/SNF family, SANT-SLIDE module (yellow) for ISWI family, tandem chromo domains (brown) for the CHD family. Figure 
is adapted from 162. 
 
 
 
Although there are different types of trans-acting factors that determine the 
accessibility of the whole genome for specific cell identity, it is possible that the TFs 
could be the dominant ones by first targeting specific loci due to their DNA binding 
specificities, and then recruiting other regulators to induce local conformational 
changes of the chromatin. In this project, I have correlated the chromatin accessibility 
data with the TFs binding activities from the same cell types to test the hypothesis that 
the TFs, especially the most active ones play dominant roles in determining chromatin 
landscape for specific cell identity due to their DNA-binding activities. 
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1.3 PIONEER TRANSCRIPTION FACTORS 
 
Although TFs are considered to initiate chromatin structural changes within 
specific loci, the ability to compete with histones for DNA binding differs a lot among 
individual TFs. Specifically, there are a group of TFs that have much higher binding 
affinity with nucleosomal DNA than others. These TFs serve as the pioneer factors to 
target the compacted genomic regions, and then recruit other TFs as well as cofactors to 
remodel the chromatin structures locally. The pioneer TFs are regarded as the 
predominant factors that initiate regulatory events within silent chromatin regions 
during transition of the cell identities.  
 
1.3.1 Interactions between pioneer TFs and nucleosomes 
  
The initial step in opening the condensed chromatin by the pioneer factors is 
their binding to the DNA target sites embedded in the chromatin. Pioneer TFs, unlike 
other TFs, have the special ability to interact with nucleosomal DNA. For instance, an 
important feature of the members of the classical pioneer TFs FOXA family is that part 
of their DNA-binding domains highly resemble that of the linker histone H1, which 
possess the “winged helix” motif that contacts the minor groove of the DNA along the 
long axis, facilitating binding of core histones on the other side of DNA166,167. In 
addition, both in vitro168 and in vivo169 experiments have shown that the FOXA TFs 
only require their DNA-binding domain to bind the target sequences on a nucleosome 
core particle. Another demonstration of interactions between pioneer TFs and 
nucleosomes comes from experiment where the classical Yamanaka factors 
(OCT4/POU5F1, SOX2, KLF4 and c-MYC) were introduced to reprogram the somatic 
cells to iPSCs3; it was shown that OCT4, SOX2 and KLF4 bound specific loci within 
condensed chromatin regions in the early stage of reprogramming, working as the 
pioneer TFs, whereas c-MYC were only able to bind open chromatin regions170. In 
order to determine the binding activities of different TFs on nucleosomes 
systematically, we have established a novel technology, nucleosome consecutive 
affinity-purification SELEX to systematically decipher the binding activity of 220 TFs 
from diverse structural families on nucleosomal DNA, greatly expanding the 
knowledge about the binding of TFs to nucleosomal DNA171.  
In addition, different kinds of modifications on histone residues, especially on 
histone 3 may also play important roles in affecting interactions between the 
nucleosomes and pioneer TFs. For instance, by comparing the epigenetic states of 
different genomic sites bound by FOXA1 in different cell types, Mathieu Lupien and 
colleagues found that FOXA1 as a pioneer factor was preferentially recruited to loci 
with high H3K4me1/2 and low H3K9me2 modifications172. There is no evidence 
indicating that there exists direct physical interaction between the FOXA1 protein and 
the H3K4me1/2 residue, and recruitment of FOXA1 pioneer factor might be influenced 
                                                                                                                                                                            
20 
by conformational changes of the chromatin induced by different epigenetic 
modifications.  
All in all, in order to understand the principles of how pioneer TFs work to 
initiate the conformational changes of local chromatin, it is necessary to decipher how 
and to what extent different kinds of pioneer TFs interact with modified or unmodified 
nucleosomes in a systematic manner.  
 
1.3.2 Pioneer TFs and development 
 
Due to the special ability of pioneer TFs to interact with nucleosomal DNA with 
high affinity, they are expected to play more important roles in determining cell 
lineages during development than other TFs as the process of development involves 
extremely dynamic and accurate changes of the chromatin architecture in different loci.  
It is already well known that the FOXA pioneer TFs are crucial for the early 
embryogenesis. Knocking out the Foxa1 gene in mice leads to early postnatal lethality 
(P2-P14) due to hypoglycemia and defects in kidney function173,174. In addition, mice 
null for Foxa2 die in the early embryonic stage (E9-E10) because of developmental 
defects in all three germ layers175,176, whereas mice deficient for Foxa3 have the mildest 
phenotype: they are viable but display more severe hypoglycemia after prolonged fast 
than the normal mice177. Apart from the FOXA family TFs, other pioneer TFs such as 
the GATA family proteins GATA4 and GATA6 also play important roles in early 
embryogenesis as mice lacking Gata4 or Gata6 die prior to the organ 
development178,179.  
Owing to the ability to bind the nucleosomal DNA with high affinity, the 
pioneer TFs are expected to spatiotemporally target specific loci in the genome during 
differentiation, and further recruit other interacting TFs as well as cofactors to execute 
modifications and conformational changes of the chromatin. For example, during the 
process of skeletal muscle differentiation, the pioneer factor PBX is responsible for 
targeting the muscle specific genes initially and recruiting other factors to induce gene 
expression180. It has also been proved that in early Caenorhabditis elegans foregut 
development, PHA-4, a homolog of FOXA genes in human, frequently binds promoters 
of gut-specific genes and recruits RNA polymerase II to enhance transcription of the 
genes181. 
Apart from actively initiating the local chromatin structural changes by 
facilitating recruitment of other factors to specific loci, the pioneer TFs can also 
passively reduce the number of subsequent binding events required for transcriptional 
activation at a later time owing to their presence at the specific regulatory regions. This 
passive model is further supported by the fact that the vast majority of promoters and 
enhancers, especially those related with lineage specific genes, always require 
cooperative binding of different TFs182-184. Furthermore, this cooperative binding model 
composed of different types of TFs also reveals the importance of other non-pioneer 
TFs during development.  
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In conclusion, the cell type specific pioneer TFs play crucial roles in targeting 
and opening up specific loci throughout the genome to induce transcription of the cell-
type specific genes with the help of other non-pioneer TFs and co-regulators.  
 
1.3.3 Pioneer TFs and tumorigenesis 
 
Apart from playing important roles in initiating local chromatin structural 
changes during normal development, pioneer TFs are also considered to be important 
for significant epigenetic alterations of the genome as well as aberrant expression of 
genes during different stages of cancer development. For example, dysregulation of 
FOXA and GATA family TFs is closely related to a variety of hormone-dependent 
tumors, such as the oestrogen receptor-positive breast cancer and the androgen 
receptor-positive prostate cancer185; the increased activity of FOXA1 for prostate cancer 
is usually predictive of poor clinical outcome of the patients186,187. Moreover, 
upregulation of the pioneer factor SOX2 is highly correlated with different types of 
cancers including lung and esophageal squamous cell carcinomas188; SOX2 is also 
considered as a key factor maintaining the cancer stem cell population that drives tumor 
initiation and therapy resistance189,190.  
Alternatively cancers may also be caused by mutations of the binding sites of 
pioneer factors rather than alterations in their activity. For example, some of the 
recurrent somatic mutations in T-cell acute lymphoblastic leukemia (T-ALL) patients, 
are known to introduce high affinity binding sites for the pioneer TF MYB upstream of 
the TAL1 oncogene resulting in TAL1 overexpression191. Genome-wide association 
studies have also linked the genetic variants, such as single nucleotide polymorphisms 
(SNPs), to the development of cancer. The majority of the SNPs are located at the non-
coding regions of the genome, implying that at least some of the mutations may alter 
binding of pioneer TFs such as FOXA1 in prostate cancer192,193. Moreover, epigenetic 
modifications rather than genetic variations could also alter pioneer TF binding as some 
specific modifications are favored by the TFs. For example, it has been demonstrated 
that multiple types of TFs, including pioneer TFs such as POU5F1 preferably bind 
methylated DNA73; it has also been reported that the progression of prostate cancer to 
an androgen-independent stage is highly correlated with the FOXA1 binding favored by 
increased H3K4 methylation at particular locus, promoting proliferation of castration-
resistant prostate cancer cells, whereas removal of the H3K4 methylation in those 
cancer cells significantly reduces the FOXA1 binding and decreases cancer cell 
proliferation194.  
Because of the primary role of pioneer TFs in cancer development, they are 
regarded as attractive molecular targets and biomarkers for cancer therapy. Recently 
scientists have put considerable effort on designing new drugs to target the pioneer TFs 
for cancer treatment. For example, different types of small peptides have been designed 
to antagonize interactions between the pioneer factor PBX1 and HOX factors to 
promote apoptosis in melanoma, ovarian and lung cancer cells195-197. Although the 
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therapeutic approaches to antagonizing FOXA1 activity are still missing, the FOXA1 
protein could act as a great prognostic biomarker for various kinds of cancers. For 
example, overexpression of FOXA1 is closely associated with metastasis in prostate 
cancer186 as well as luminal subtype A breast cancer198-200. Co-expression of FOXA1 
and GATA3 characterizes the luminal breast tumors and is a predictor of higher 
survival200-202. Targeting the pioneer TFs may have great potential in the future cancer 
treatments, however, a better understanding of how pioneer factors function to change 
the cell fate during initiation and development stages of cancer will be required in order 
to target them reliably for therapeutic breakthroughs. 
Taken together, the pioneer TFs contribute significantly to cancer development 
either through mutations of their coding sequences, modulation of their expression or 
alteration of their genomic activities. They have thus great potential as therapeutic 
targets and biomarkers in cancer treatment.  
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2 AIMS OF THE STUDY 
 
 
This study aimed at deciphering the most active and important transcription 
factors for specific cell identity. By establishing a novel technology to measure the 
global transcription factor activity in cells, we aimed to compare the DNA-binding 
activities of all TFs inside the cell nucleus, and decipher the dominant TFs that set up 
the whole transcriptional regulatory architecture in particular cell types.  
  
More specifically, we divided the goal into three parts: 
 
1) Establishing a novel method to measure the DNA-binding activities of all 
TFs in different cell types, and verifying the results by reprogramming of 
fibroblasts to the target cell identity. 
 
2) Studying the correlation between binding activity of TFs and chromatin 
accessibility in the same cell identity to prove the dominant role of TFs in 
determining chromatin landscape for specific cell identity. 
 
3) Determining the pioneer TFs for different cell identities by using 
nucleosomal DNA instead of naked DNA in the assay. 
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3 MATERIALS AND METHODS 
  
3.1 MATERIALS 
 
3.1.1 Reagents and commercial kits 
 
The reagents and commercial kits used in the thesis are clearly indicated in the 
“METHODS” section of the thesis.  
 
3.1.2 Cells lines 
 
The mouse embryonic stem (ES) cells and MEF feeder cells were obtained from 
Karolinska Center for Transgene Technologies. The mouse ES cells were authenticated 
by production of germline chimeric mice, alkaline phosphatase staining and cell 
morphology.  
The human fibroblast cell line CCD-1112Sk was purchased from ATCC (Cat 
no. CRL 2429); the human 293FT cell line was purchased from Thermo Scientific (Cat 
no. R70007); the Drosophila S2 cell line was purchased from Thermo Scientific (Cat 
no. R69007). 
 
3.1.3 Animals 
 
The mice used in this thesis were all adult male with the wild-type (C57BL/6J) 
genetic background.  
 
 
3.2 METHODS 
 
3.2.1 Cell culture & Protein extraction 
 
The Mouse embryonic stem (ES) cells (C57BL/6J; from KCTT center at 
Karolinska Institutet) were first plated on 150 mm × 25 mm petri dishes in ES1+LIF 
medium with or without MEF feeder layers and changed to 2i+LIF medium after the 
cells attached to the plates; cells were split every two or three days and collected by 
trypsinization at 70-80% confluence, the MEF feeder cells were removed using 
differential adhesion method203 for the final collection. The ES1+LIF medium is 
composed of knockout DMEM medium (Gibco, Cat no. 10829-018) supplemented by 
15% fetal bovine serum (Sigma, Cat no. F7524), 2 mM L-Glutamine (Gibco, Cat no. 
25030-024), 0.1 mM of each Non-Essential Amino Acids (Gibco, Cat no. 11140-035), 
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0.1 mM β-mercaptoethanol (Thermo Scientific, Cat no. 31350-010), 10 µg/ml 
Gentamicin (Thermo Scientific, Cat no. 15710-049), 10 mM HEPES (Gibco, Cat no. 
15630-056) and 1000 U/ml Leukemia inhibitory factor (LIF, Millipore, Cat no. 
ESG1107). The 2i+LIF medium is composed of knockout DMEM medium with 20% 
KnockOut™ Serum Replacement (Gibco, Cat no. 10828-028), 2 mM L-Glutamine, 0.1 
mM of each Non-Essential Amino Acids (Gibco, Cat no. 11140-035), 0.1 mM β-
mercaptoethanol (Thermo Scientific, Cat no. 31350-010), 10 µg/ml Gentamicin 
(Thermo Scientific, Cat no. 15710-049), 1 µM MEK inhibitor PD0325901 (Miltenyi 
Biotec, Cat no. 130-103-923), 2 µM GSK-3α/β inhibitor BIO (Sigma, Cat no. B1686) 
and 1000 U/ml LIF. 
The Human fibroblast cell line CCD-1112Sk (ATCC, Cat no. CRL 2429) and 
the highly transfectable 293FT cell line were both cultured in  DMEM medium 
supplemented with 10% fetal bovine serum and antibiotics (100 units/ml of penicillin 
and 100 µg/ml streptomycin). 
The S2 cells (Thermo Scientific, Cat no. R69007) from Drosophila were 
cultured in Schneider’s Drosophila Medium (Thermo Scientific, Cat no. 21720024) at 
27 °C without CO2 and harvested by trypsinization. 
The ES cells for neural differentiation were cultured with 2i medium 
supplemented with 2 µM retinoic acid (Sigma, Cat no. R2625-100MG) for 2 days; the 
ES cells for mesodermal differentiation were first cultured with 2i+LIF medium for 
16 hours, and then changed to the mesodermal medium and cultured for 30 more 
hours; the control ES cells were cultured in 2i+LIF medium without feeder layers. 
The mesodermal medium (206 ml) includes: 100 ml IMDM (Thermo Scientific, Cat 
no. 12440053) supplemented with GlutaMAX (Thermo Scientific, Cat no. 31980030), 
100 ml Ham's F-12 Nutrient Mix (Thermo Scientific, Cat no. 21765029), 2 ml N2 
supplement (100×, Thermo Scientific, Cat no. 17502048), 4 ml B27 supplement (50×, 
Thermo Scientific, Cat no. 17504044), 0.5 mM ascorbic acid (Sigma, Cat no. 
A92902), 4.5 × 10-4 M monothioglycerol (Sigma, Cat no. M1753), 5 ng/ml VEGF 
(Thermo Scientific, Cat no. PHC9391), 8 ng/ml Activin A (Thermo Scientific, Cat no. 
PHG9014) and 0.5 ng/ml BMP4 (Thermo Scientific, Cat no. PHC9534).  
The protein extraction was performed with “Subcellular Protein Fractionation 
Kit for Tissues” (Life Technologies, Cat no. 87790). The nuclear soluble proteins 
were obtained by following the instructions provided with the kit, except for changing 
the protease inhibitors included in the kit to the protease inhibitors (Roche, Cat no. 
05892791001) and phosphatase inhibitors (Roche, Cat no. 04906845001). The 
nuclear soluble extract were supplemented with 5% glycerol (v/v), divided into 5 µl 
aliquots in each tube, snap froze in liquid nitrogen and stored at -80 °C for future 
usage. 
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3.2.2 Induced hepatocytes reprogramming assay 
 
The 293FT cells were first transfected with lentiviral expression vector 
pLenti6/V5 with individual genes together with packaging vectors psPAX2 and 
pMD2.G (Addgene) using the Lipofectamine 2000 transfection reagents (Thermo 
Scientific, Cat no. 11668019) according to the manufacturer’s instructions, and then 
replenished with fresh culture medium one day after the transfection. The lenti-viruses 
were harvested 48 hours after the transfection and further concentrated.  
The early passage human fibroblasts were seeded on day 0, and then transduced 
with combinations of TFs on day 1 in the presence of polybrene (8 µg/ml final 
concentration; Sigma, Cat no. TR-1003-G). The medium containing viruses were 
changed to standard medium one day after transduction (day 2) and then changed to 
defined hepatocyte culture medium (HCM; Lonza, Cat no. CC-3198) on day 3. The 
medium was changed every other day, and on day 7 the cells were trypsinized and 
replated on type-I collagen coated plates in HCM medium. On day 29, the cells were 
again passaged to new type-I collagen coated plates and cultured until six weeks after 
transduction. The cocktails of TFs applied to the reprogramming assay were based on 
previous studies from Morris et al.204 (FOXA1, HNF4A, KLF5), Du et al.205 (HNF4A, 
HNF1A, HNF6, ATF5, PROX1, CEBPA), Huang et al.206 (FOXA3, HNF4A, HNF1A), 
and the nine specific TFs identified by ATI from mouse liver (HNF1A, HNF1B, DBP, 
MAFG, CEBPA, CEBPB, HNF4A, HNF6/ONECUT1, ESRRA). 
The cells were harvested at different time points, and the total RNA were 
extracted and followed by cDNA synthesis with the “Power SYBR™ Green Cells-to-
CT™ Kit” (Thermo Scientific, Cat no. 4402954). 
 
3.2.3 Active TF identification assay 
 
The assay was performed in vitro by mixing 5 µl protein extract obtained from 
previous protein extraction step, 5 µl 140 bp double stranded DNA (dsDNA) oligos 
containing 40 bp random sequence in the middle (10 pmol) and adapter sequences on 
both ends, and 5 µl 3 × protein binding buffer (420 mM KCl, 15 mM NaCl, 3 mM 
K2HPO4, 6 mM MgSO4, 300 µM EGTA and 9 µM ZnSO4, 60 mM HEPES, pH = 7.5) 
and incubating for 30 min at room temperature. The non-specific competitor poly-dIdC 
was supplemented in the reaction (5 ng/ µl final concentration). After the reaction, the 
electrophoretic mobility shift assay (EMSA) was carried out using 6% DNA 
Retardation Gel (Invitrogen, Cat no. EC63652BOX) in 0.5 × TBE buffer (1 mM EDTA 
in 45 mM Tris-borate, pH 8.0) with 106 V constant voltage for 70 min. The gel above 
the 300 bp DNA marker was collected, eluted in 300 µl Tris buffer (10 mM Tris-Cl, pH 
8.0) and incubated at 65 °C for 3 hours. The eluted DNA was amplified with Phusion 
polymerases (Thermo Scientific, Cat no. F530L); 4 pmol of each primer were used for 
the amplification. Before the final step of amplification, the same amount of primers 
was added to convert the single stranded DNA (ssDNA) to dsDNA. The amplified 
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DNA library was incubated again with aliquot of the same protein extract as above and 
the whole process was repeated for three more times. The PCR products with different 
barcodes were pooled and purified with QIAquick PCR Purification Kit (Qiagen, Cat 
no. 28106) for library preparation for next generation sequencing with Illumina 
instruments.  
 
3.2.4 Bioinformatical analysis of ATI data 
 
Two independent methods were utilized to analyze the ATI data to measure 
the enrichment of motifs, which reflected the total binding activities of corresponding 
TFs or TF families in the cell extract. The de novo motif discovery method  utilized 
the “Autoseed” program13 to detect the most significant motifs. Up to 200 highest 
count local maxima 10 bp sequences (with or without a gap at the center) were used 
as seeds to generate initial position weight matrix (PWM) motifs, which were further 
investigated manually to remove low complexity motifs and motifs that were highly 
similar.  
The known motif enrichment analysis measured the enrichment of known 
motifs from the SELEX database14,73 (including DNA-dependent dimeric motifs) 
based on the MOODS program207,208. First the frequency of each motif was calculated 
utilizing the MOODS program in cycle 1 and cycle 4 sequencing data with one cutoff 
(p-value ≤ 0.0001, Score > 11) based on the PWM of the motif. Subsequently, the 
enrichment and p-value (Winflat209) were calculated for each motif by comparing the 
frequencies of the motif in cycle 4 and cycle 1 sequencing data; the sensitivity to 
detect differences using this method was very high, and it could detect highly 
statistically significant differences whose fold-changes were probably too low to be 
detected by the de novo motif discovery method.  
 
3.2.5 Analysis of DNase I hypersensitive sites (DHSs) 
 
The DHSs data from different mouse tissues and ES cells were obtained from 
the ENCODE project210, including 14 replicates for mouse liver, 7 replicates for 
mouse brain, 2 replicates for mouse heart, spleen and ES cells. The top 5,000 regions 
for each replicate were selected from the BroadPeak data set based on Signal Values. 
For samples with two replicates, the intersected regions were used for downstream 
analysis, resulting in around 4,000 DHSs for each tissue; for liver, DHSs overlapped 
by more than 8 replicates were selected to reach 3,806 DHSs, which were comparable 
with the other tissues; for brain, DHSs overlapped by more than 4 replicates were 
selected, resulting in 3,645 DHSs. Meanwhile, frequencies of all different 10-mers on 
both strands were counted in the ATI data; the fold change for each 10-mer was 
calculated by comparing the frequencies of it in the last cycle (Cycle 4) and the first 
cycle (Cycle 1). After that, the DHSs and the 10-mer results from the same tissues 
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were analyzed. First, each DHS site was flanked by adjacent genomic sequences 
(non-DHS regions) to achieve a 10 kb region, resulting in ~ 4,000 regions with the 
length of 10 kb for each tissue and cell type, all these 10 kb regions were then aligned 
by using the middle of the DHS as the center position. Within the 10-kb sequences, 
each position was regarded as a 10 bp sequence with that particular position as the 4th 
nucleotide; the score for each position was then calculated based on the log2 fold 
change of the corresponding 10-mer in ATI data.  
The DHS sites were predicted from above mentioned 10 kb regions as well as 
from the whole genome. First, the scoring of the 10-mers was optimized by trying 
different cutoffs using a separate training set (setting separately top 0.1%, top 0.5%, 
top 1%, top 5%, top 10%, top 20%, top 40%, top 60% and top 100% of the 10-mers 
as score 1 and the remaining 10-mers as score 0, 100% of 10-mers is considered as a 
negative control), resulting in the optimal cutoff by setting the top 1% enriched 10-
mers as score 1 and the remaining 10-mers as score 0. The 10 kb regions were divided 
to 50 bp bins, and each bin was then assigned with the mean score of all sliding 10-
mers inside the bin. The DHS position was then called based on identification of the 
highest score in a sliding window of 17 bins. The optimal width of the smoothing 
window was determined by using half of the 10 kb regions as a training set; only the 
test set data is shown on Figure 4.5c for ES cells. 
 
3.2.6 Capturing DNA-binding proteins using biotinylated ATI ligands 
 
The DNA-binding proteins from the nuclear extract were captured as 
previously reported211. First, DNA oligonucleotides were amplified with biotinylated 
primers (modified with Biotin-TEG) and purified with QIAquick PCR Purification 
Kit (Qiagen, Cat no. 28106) to get rid of extra primers. Subsequently, 2 µg of 
biotinylated DNA library were incubated with 4 µl of high-performance streptavidin 
Sepharose (GE Healthcare, 17511301) in 100 µl DNA binding buffer (10 mM 
HEPES, pH 8.0, 1 M NaCl, 10 mM EDTA, and 0.05% NP40) for 1 hour at room 
temperature by shaking. Beads were then washed twice with 100 µl DNA binding 
buffer and twice with 100 µl protein binding buffer (140 mM KCl, 5 mM NaCl, 1 
mM K2HPO4, 2 mM MgSO4, 100 µM EGTA and 3 µM ZnSO4, in 20 mM HEPES, 
pH = 7.5). 200 µl Nuclear extract from feeder-free mouse ES cells containing 200 µg 
proteins was mixed with the washed beads and incubated for 1.5 hours by shaking at 
room temperature. 2 µg poly-dIdC competitor DNA and EDTA-free complete 
protease inhibitors (Sigma, Cat no. 000000004693159001) were supplemented to the 
reaction. The beads were then washed with ice-cold low stringency buffer (10 mM 
Tris-Cl, pH 7.5, 4% glycerol, 500 µM EDTA, 50 mM NaCl) for 10 times and 
proceeded to on-beads digestion for MS211. 
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3.2.7 Sample preparation for mass spectrometry 
 
After capturing DNA-binding proteins from the nuclear extract, the washed 
beads were incubated in 50 µl of buffer containing 25 mM ammonium bicarbonate 
and 1 mM dithiothreitol (DTT) for 1 h at 37 °C, and followed by addition of 5 mM 
Iodoacetic acid (IAA) in the buffer for incubation in the dark for another 10 min. 
Extra DTT were supplemented to the final concentration of 5 mM to quench the 
reaction. The proteins were digested by directly incubating the beads with Lys-C 
protease (0.2 µg/sample; Thermo Scientific, cat. no. 90051) overnight at 37 °C, 
followed by digestion with trypsin protease (0.1 µg/sample; Thermo Scientific, cat. 
no. 90057) for another 10 hours at 37 °C.  
Around 500 µg labeled peptide pool was dissolved in 250 µl of rehydration 
buffer containing 8 M urea and 1% Pharmalyte (pH 3–10, from GE Healthcare), 
followed by re-swelling an immobilized pH gradient (IPG) gel strip (GE 
Healthcare) at pH 3–10. The isoelectric focusing (IEF) was performed on an Ettan 
IPGphor isoelectric focusing system (GE Healthcare) to at least 150 kVh for 
around one day. After focusing, the MilliQ water was supplemented with the 
liquid-handling robotics (GE Healthcare prototype) for incubation/extraction of 
peptides. The extracted peptides were transferred into a microtiter plate (96 wells, 
V-bottom, Corning cat. no. 3894). The extraction was repeated three more times, 
and the combined samples on the microtiter plate were dried using a vacuum 
microcentrifuge. 
 
3.2.8 Label-free mass spectrometry 
 
Label-free mass spectrometry (MS) of peptides was operated using a hybrid 
Q-Exactive mass spectrometer (Thermo Scientific). The sample was resuspended in 
10 µl of solvent A (5% DMSO and 0.1% formic acid (FA) in water), and 3 µl of it 
was injected. Peptides were trapped on an Acclaim PepMap nanotrap column (C18, 
3 µm, 100 Å, 75 µm × 20 mm) and separated by an Acclaim PepMap RSLC 
column (C18, 2 µm, 100 Å, 75 µm × 50 cm, Thermo Scientific). Separation of 
peptides were performed by using a gradient of solvent A and solvent B (90% 
acetonitrile (ACN), 5% DMSO and 0.1% FA in water), with solvent B ranging 
from 6% to 37% in 240 min with a flow of 0.25 µl/min. Q-Exactive (QE) was 
performed in a data-dependent manner. First the FTMS (Fourier Transform Mass 
Spectrometry) survey was performed by scanning at 70,000 resolution (and mass 
range 300–1,700 m/z) followed by MS/MS (35,000 resolution) of the top five ions 
using higher-energy collision dissociation (HCD) at 30% normalized collision 
energy. Then precursors were isolated with a 2-m/z window, by setting the 
automatic gain control (AGC) as 1 × 106 for MS1 and 1 × 105 for MS2. Maximum 
injection times were 100 ms for MS1 and 150 ms for MS2. The entire duty cycle 
lasted around 1 s, and dynamic exclusion was applied with a 60s duration. 
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Precursors with unassigned charge state or a charge state of 1 were excluded, and 
underfill ratio of was set as 1%. 
 
3.2.9 Peptide and protein identification 
 
To determine the unique peptides and proteins, MS raw files were searched 
with the Sequest-percolator in Proteome Discoverer 1.4 software (Thermo 
Scientific) against the Uniprot mouse database (version 2016_10, canonical and 
isoforms, 85,832 protein entries) and filtered to a 1% false discovery rate (FDR) 
cut-off (peptide-spectrum-match level). A maximum of two missed cleavages was 
used together with: carbamidomethylation (C) set as fixed modification and 
oxidation (M) set as a variable modification. A precursor ion mass tolerance of 10 
p.p.m. and a product ion mass tolerance of 0.02 Da for HCD spectra were applied. 
The average area of the top three peptide spectrum matches (PSMs) for each 
protein group was used to calculate protein area. Only unique peptides in the data 
set were used for quantification.  
 
3.2.10 Reconstitution of nucleosomes 
 
The nucleosomes were reconstituted as described previously212. First, 100 ng 
dsDNA were incubated with 50 ng histone octamers tagged with streptavidin binding 
peptide (SBP) in 2 M KCl solution (10 µl) for 30 min at room temperature. The 
solution was diluted stepwise by addition of dilution buffer (TE buffer supplemented 
with 1 mM tris (2-carboxyethyl) phosphine (TCEP) and a cocktail of protease 
inhibitors) until the final KCl concentration reached around 140 mM. The volumes of 
the subsequent buffer additions were 10 µl, 5 µl, 5 µl, 5 µl, 5 µl, 60 µl, 40 µl, each 
followed by one hour incubation. The DNA oligos were designed to contain 101 bp 
random sequences in the middle and flanked by 24 bp and 22 bp adapter sequences on 
both ends, resulting in the total length of 147 bp.  
 
3.2.11 ATI assay by using nucleosomes 
 
The reconstituted nucleosomes were first immobilized by the streptavidin-
coated magnetic beads (28-9857-99, GE Healthcare; pre-blocked with the blocking 
buffer containing 25mM Tris, 0.5% BSA, 0.1% tween 20, 0.02% NaN3) and washed 
using the protein binding buffer which was used in the standard ATI assay. Nuclear 
proteins extracted from particular cell types were added directly to the beads and 
incubated at room temperature for 90 min. For one single reaction, the total volume 
was 20 µl, including 0.5 pmol nucleosomes, 20 µg nuclear extract, and 5% w/v 
PEG4000 (Sigma, Cat no. 1546569-1G) in the same protein binding buffer used in the 
standard ATI assay. The DNA ligands dissociated from the histones were collected 
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from the supernatant. Meanwhile, the complex still bound to the beads were eluted by 
protein binding buffer supplemented with 10 mM biotin, and subjected to EMSA to 
separate the ligands that were bound by both histones and proteins from the nuclear 
extract. The ligands both from the supernatant and separated by EMSA were 
separately PCR-amplified and used for next cycle; the process was repeated for two 
more times.  
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4 RESULTS 
 
4.1 STUDY I: DECIPHERING MOST ACTIVE TFs BY ATI 
 
4.1.1 Extraction of nuclear soluble proteins 
 
Since the binding activities of TFs are important for the cell identity, it is 
necessary to quantify the activities of different TFs located in the cell nucleus in order 
to decipher the mechanism of cell fate determination. Due to the development of 
technologies to study the binding specificity of TFs, especially the high-throughput 
systematic evolution of ligands by exponential enrichment (HT-SELEX), we have 
determined the binding specificity of most TFs in humans71 and flies13. In this project, 
we established a novel method, active TF identification (ATI) assay to measure the 
DNA-binding activities of all TFs in cell nucleus.  
Firstly, the nuclear soluble proteins were extracted from the cultured cells or 
fresh tissues. The proteins located outside the nucleus are not responsible for the 
transcriptional regulation occurring within the nucleus and therefore the cytosolic 
fraction was discarded. In addition, the extraction of nuclear soluble proteins was 
carried out at 400 mM salt concentration in order to extract most TFs together with 
epigenetic regulators but not the histones (Figure 4.1). Histones possess a certain 
degree of specificity in their DNA binding and as such could generate considerable 
noise in the assay.  
 
 
Figure 4.1 Subcellular protein extraction from cultured cell lines and fresh tissue 
Immunoblotting assay (IB) was performed on extracts from GP5D human colorectal cancer cells and mouse brain tissue. The 
antibodies used are against proteins from the five different compartments including HSP90 from cytoplasmic extract (CE), EGFR 
from membrane extract (ME), TOPO I and HDAC2 from nuclear soluble extract (NE), histone H3 from chromatin-bound extract 
(CB), and VIMENTIN (VIM) from cytoskeleton extract (PE).  
  
GP5D cells Mouse brain
CE- HSP90
IB:
ME- EGFR
NE- TOPO I
NE- HDAC2
CB- H3
PE- VIM
CE- HSP90
ME- EGFR
NE- TOPO I
NE- HDAC2
CB- H3
PE- VIM
CE ME NE CB PE CE ME NE CB PE
  33 
4.1.2 Active TF identification (ATI) assay  
 
Next, the ATI assay was performed by incubating a library of double-stranded 
DNA containing 40 bp random sequences with a nuclear extract from particular cell or 
tissue type. The DNA bound by TFs was then separated from the unbound DNA by 
electrophoretic mobility shift assay (EMSA, Figure 4.2a). The bound DNA ligands 
were eluted from the gel and amplified by PCR, and the entire process was repeated 
three more times. Comparison of millions of sequences derived from the input and the 
selected libraries then allows identification of enriched binding motifs that correspond 
to the TFs present in the nuclear extract. The logic of this method is similar with 
proteomics, as each binding motif is regarded as the fingerprint of the particular TF or 
TF family, and the total binding activity for each individual TF or TF family can be 
determined by the total enrichment of the corresponding motif after four cycles 
selection in ATI. One concern is that the binding motif may be corresponding to one 
single TF or a group of TFs sharing the same DNA binding domain (DBD). In order to 
determine which TF from the same group is responsible for the enrichment of the 
related motif, we supplemented the ATI assay with a mass spectrometry identification 
process after capturing proteins from the same cell types by using the enriched DNA 
library (Figure 4.2a).  
We applied the ATI method to different cell or tissue types, including mouse ES 
cells, heart, spleen, brain and liver dissected from one year old wild-type male mouse. 
By using the Autoseed program for de novo motif mining, we are able to detect around 
10 distinct motifs for each sample (Figure 4.2b). Among these motifs, five of them are 
commonly active in all the cell or tissue samples tested, indicating that the 
corresponding TFs/TF families, including NRF1, NFI, bHLH, Nuclear Receptors (NR) 
and bZIP, are generally active in all cell types, acting as the housekeeping TFs. Three 
motifs are detected in more than two out of five samples, corresponding to TFs/TF 
families YY1/2, ETS and RBPJ; identification of these “shared” TFs/TF families 
indicates that the transcriptional regulatory network cannot be totally unique for 
particular cell identity, and part of the network is shared by other cell types. Moreover, 
we also detected “specific motifs” in only one or two out of five samples, indicating the 
unique roles of the corresponding TFs/ TF families in the specific cell identity. In 
addition, we also detected enrichment of some unknown motifs (Figure 4.2b, bottom), 
which we could not assign to a known TF based on the current knowledge (HT-SELEX 
motifs, CIS-BP, TOMTOM12,13,71,213). Overall, we recovered 35 motifs, of which only 
six (17%) were unknown, indicating that specificities for most of the TFs that display 
strong activity in the tested tissue types have already been determined. 
In addition to discovery of TFs binding motifs, the quantitative information on 
binding activity of TFs can also be obtained from the de novo motif mining method. By 
comparing the enrichment of the “common” motifs shared by all the samples tested 
(Figure 4.2c), we found that the binding activity of the same TF/TF family varied a lot 
in different cell or tissue types, implying additional specific roles of them in different 
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cell types. For instance, the NFI family motif was most highly enriched in the liver, 
indicating that the NFI family TFs in liver not only perform fundamental duties as the 
house keeping TFs, but also regulate expression of liver specific genes as the liver 
specific TFs; in addition, the enrichment of NRF1 motif was extremely high in spleen 
compared with other cell and tissue samples, implying the specific role of TF NRF1 in 
spleen. In general, our ATI results provide both qualitative and quantitative information 
about the binding activity of TFs. 
Apart from the de novo motif mining, we also performed known motif 
enrichment analysis on the ATI sequencing data by means of MOODS program, which 
calculated the enrichment of all known motifs from our SELEX database in the 
enriched DNA library (cycle 4) compared with the DNA library after one round 
selection (cycle 1). The enrichment of the motif reflects the binding activity of the 
corresponding TF/TF family in cells. In general, known motif enrichment analysis 
results were consistent with motifs discovered by using the de novo discovery method, 
and revealed additional TFs whose motifs were specifically enriched in different cell 
types or tissues. For example, motifs for pluripotency factors such as GLIS2 were 
detected in mouse ES cells with the known motif enrichment analysis, albeit with a 
relatively low enrichment; from the mouse liver, we also detected motifs for liver 
specific TFs such as ONECUT and HNF4A (Figure 4.2b).  
Taken together, the ATI results from the tested cell and tissue samples revealed 
that in addition to five commonly active TFs, each tissue or cell type displayed strong 
DNA-binding activity of key regulators of the respective cell identity. 
 
4.1.3 Identifying specific transcription factors by MS 
 
 The ATI technique is quite useful to identify the most active motifs in 
different cell types, but in most cases, it cannot identify the specific TFs that are active 
in cells, due to the fact that many TFs within the same structural family share the same 
binding motif. In order to identify the specific TFs that cannot be determined by their 
binding motifs only, we captured the proteins from nuclear extract of mouse ES cells by 
using the control and enriched ATI DNA libraries, and performed mass spectrometry 
(MS) analysis on the captured proteins. Based on the MS results, we managed to 
identify specific TFs corresponding to active motifs (Table 4.1). For example, the POU 
family protein POU5F1 was detected with high abundance in the ES cells, indicating 
that POU5F1, rather than other POU family proteins was predominantly active in the 
ES cells; the MS result also revealed that the KLF4 protein was the most active KLF/SP 
family TF in the ES cells. In most cases, the abundance of TFs captured by the enriched 
DNA library was higher than those enriched by the original DNA library, indicating 
that the DNA ligands containing specific motifs from the original library are fully 
captured by corresponding TFs, but those ligands from the enriched library may not be 
saturated. However, there was one exception- the abundance estimate of ZIC family 
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TFs was higher when using the original DNA library than using the enriched DNA 
library, which might be caused by random variation of the MS assay.   
 
 
 
 
 
Figure 4.2 Determining the most active TFs in cells by means of ATI assay 
a) Schematic description of the active transcription factor identification (ATI) assay. A pool of dsDNA ligands is incubated with 
nuclear extract of cells or tissues; the oligos bound by the nuclear proteins are selected against the unbound ones by native PAGE gel 
purification (EMSA; right) and amplified. The process is done in four cycles, resulting in an enriched DNA pool that reflects binding 
activities of the TFs in the cell lysate. Both the original and enriched DNA libraries are subjected to next generation sequencing for 
motif analysis. TFs are also captured by incubating the nuclear extract and a biotinylated oligonucleotide pool consisting of the 
identified ligands, and followed by MS (left) for quantification of the proteins. 
b) The most highly enriched motifs and the corresponding TFs identified by de novo motif discovery from different cell or tissue 
types. The TFs known to contribute to lineage determination in the analyzed samples are indicated by asterisks. The names of the 
TFs are based on the motifs. In cases where multiple TFs share the same binding motif, the representative TF is indicated based on 
the mRNA expression levels and functional data from previous studies. Examples of TFs known to be important for the specific 
tissues whose motifs were identified by only using the known motif discovery pipeline are also indicated in “specific weak signals”. 
Some detected but unknown motifs are also shown on the bottom. 
c) Variation of DNA-binding activities for common TFs in different tissue or cell types. The bars represent the relative binding 
activities of the “common” motifs in different tissue or cell types, which is based on increase of absolute molecular counts214 of each 
motif between the original library (cycle 0) and the selected library after the last cycle (cycle 4). The activities of each TF were 
normalized by setting its highest activity in any of the tissues to 1.   
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Table 4.1 Identification of specific TFs based on the MS result  
                      ND: Not determined 
 
 
 
4.1.4 Binding activity changes during differentiation  
 
To study the activity changes of TFs during dynamic processes, we applied the 
ATI assay to compare the TF binding activity in ES cells and the differentiated cells 
(Figure 4.3a). The mouse ES cells were induced towards neural and mesodermal 
lineages using standard conditions215-217, and the enrichment of each motif in different 
lineages was compared with its enrichment in ES cells, revealing the binding activity 
changes during the differentiation. Because the original DNA libraries are the same for 
different samples, relative enrichment for each motif in different samples is then equal 
to the ratio of the frequencies for each motif in corresponding cycle 4 DNA libraries. 
The results indicated that several known quantitative changes in TF binding activities 
accompanied the neural and mesodermal differentiation processes. For instance, the 
activities of the pluripotency factors GLIS and ZIC were decreased, whereas the 
activities of RFX and PAX factors that are known to contribute to neural differentiation 
were increased (Figure 4.3b and c). Similarly, the activities of GLIS and ZIC factors 
decreased after induction of mesodermal differentiation, whereas the activity of the 
known mesodermal factor AP2 increased significantly (Figure 4.3b and d). However, 
the activation of SMAD proteins by BMP4 and Activin A that were used to induce 
mesodermal differentiation was not detected, potentially due to the fact that interactions 
between SMAD proteins and the DNA are too weak (Kd ≈ 1 × 10-7 M), and often rely 
on some other TFs218. In contrast, ATI robustly detected the activation of retinoic acid 
TF detected TF detected Protein area
in ATI
Protein area Fold change
in Cycle 0 (C0) in Cycle 4 (C4) (C4/C0)
RBPJ RBPJ 2,81E+09 3,86E+09 1,37
bHLH USF1 7,94E+08 2,14E+09 2,70
NRF1 NRF1 2,74E+07 3,24E+07 1,18
YY1/2 YY1 3,04E+08 3,55E+08 1,17
AP2 TFAP2C 4,49E+08 4,71E+08 1,05
CEBP CEBPG 9,12E+07 2,09E+08 2,29
KLF/SP KLF4 3,19E+08 4,21E+08 1,32
POU POU5F1 5,59E+08 7,13E+08 1,28
NFY NFYA 3,12E+08 4,85E+08 1,55
NFI NFIB 6,96E+06 2,25E+07 3,24
NR RARG 1,56E+08 1,67E+08 1,07
ETS ERF 1,30E+08 1,36E+08 1,05
ZIC ZIC3 6,64E+08 3,94E+08 0,59
ESRR ESRRB 2,32E+09 2,22E+09 0,96
RFX RFX1 1,65E+08 2,80E+08 1,69
SRF ND N/A N/A N/A
in MS
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receptor, one type of nuclear receptor (NR), by the neural inducer retinoic acid (Figure 
4.3b and c), indicating that some ligand-inducible TFs can be detected by ATI.   
 
Figure 4.3 Analysis of TF activity changes during ES cell differentiation 
a) Morphology changes of mouse ES cells (left) differentiated into neural (middle) and mesodermal (right) lineages. Scale bars, 400 
µm.  
b) Comparison of binding activity of TFs /TF families detected by the de novo motif discovery method in the control and 
differentiated mES cells. Bars indicate the relative activities of the indicated TFs/TF families based on increase of the absolute 
molecular counts214 of the corresponding motif from cycle 1 to cycle 4. For each TF/ TF family in different lineages, their activities 
were normalized by setting the highest activity in any of the three conditions to 1. 
c, d) Comparison of motif enrichment between the neural (c) or mesodermal (d) differentiated ES cells and the control 
undifferentiated ES cells by using the known motif frequency analysis method. The y axis indicates the p value (log scale, calculated 
by winflat219; owing to the precision of calculation, many p values were set to a minimum of 1 × 10−300); the x axis indicates fold 
change. Motifs with p < 1 × 10−10 and more than 20% changes are indicated in red (enriched in neural or mesodermal differentiated 
ES cells) or blue (enriched in control ES cells), respectively, with the names of representative motifs indicated. The black dots 
represent motifs that changed less than 20% and/or did not pass the p-value threshold. 
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4.1.5 Reprogramming of induced hepatocytes with overexpression of specific TFs 
detected in ATI 
 
In order to prove that the TFs we have found in the ATI assay are the master 
regulators of the specific cell identities, we performed the reprogramming assay to 
convert the fibroblasts to hepatocytes by overexpressing nine TFs that were specifically 
detected in adult mouse liver (Set_ATI), namely HNF1A, HNF1B, CEBPA, CEBPB, 
DBP, MAFG, ESRRA, HNF4A and HNF6/ONECUT1, and investigated the 
morphology of the cells and expression of the liver specific marker gene ALBUMIN 
after two weeks of culture. We also performed the reprogramming assay using other 
combinations of TFs that were previously published204-206 (Set_a, Set_b and Set_c).  
The result indicated that by overexpressing those nine liver specific TFs, the 
fibroblasts were successfully converted to induced hepatocytes (iHeps) two weeks after 
transduction, in a manner comparable to the other three methods described previously. 
Moreover, the expression level of ALBUMIN in Set_ATI was one of the highest among 
all four sets, indicating its high efficacy. Taken together, our iHeps reprogramming 
assay revealed that by introducing nine liver specific TFs detected in the ATI assay, we 
were able to convert the fibroblasts to hepatocytes at an efficiency similar to that of the 
most efficient previously described protocol.  
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Figure 4.4 Reprogramming of human fibroblast to induced hepatocytes 
a) Bright field images of iHep colonies from human fibroblasts after lentiviral transduction of TF combinations previously reported 
in Morris et al.204 (Set_a; FOXA1, HNF4A, KLF5), Du et al.205 (Set_b; HNF4A, HNF1A, HNF6/ONECUT1, ATF5, PROX1, 
CEBPA), Huang et al.206 (Set_c; FOXA3, HNF4A, HNF1A) and factors identified by ATI in mouse liver (Set_ATI; HNF1A, 
HNF1B, DBP, MAFG, CEBPA, CEBPB, HNF4A, HNF6, ESRRA). Scale bars, 400 µm. 
b) Relative expression levels of the liver-specific marker gene ALBUMIN in iHep cells normalized to GAPDH levels by RT-PCR 
using previously reported TF cocktails and ATI-identified TF combinations. Bars indicate the means of two independent duplicate 
samples, and the dots indicate values for each duplicate sample. 
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4.2 STUDY II: CORRELATION BETWEEN DHSs AND ATI DATA 
 
Due to their binding specificity with DNA, TFs are considered to be the most 
important trans-acting factors required to set up the chromatin landscape in cells. In 
order to determine whether ATI also confers information on the mammalian chromatin 
landscape, we compared the ATI data with DNase I hypersensitive sites (DHSs) in 
mouse ES cells from the mouse ENCODE project210. This analysis revealed that the top 
2000 most enriched 10-mers detected by ATI in mouse ES cells were strongly enriched 
in the ~ 5000 most significant DHS regions from the ES cells (Figure 4.5a). Moreover, 
we also performed the same analysis on other mouse tissues, resulting in significant but 
weaker enrichment than the ES cells (data not shown). The reason may be that ES cells 
are more homogenous than tissues containing multiple different cell types. Further 
analysis of 10-mers enriched in both DHSs and ATI data from ES cells revealed that 
there were many 10-mers that were enriched in both, and that all of these 10-mers were 
related to the ATI motifs (Figure 4.5b). However, there were some other 10-mers only 
enriched in DHSs (Figure 4.5b), including many repetitive CG rich sequences that 
were enriched in gene regulatory elements due to the fact that methylated C is prone to 
mutation, and the low CpG methylation rate of regulatory elements protects these 
sequences from this mutational process220,221.  
We further hypothesized that we could predict the DHS regions using the ATI 
enriched subsequences since ATI could accurately represent TF binding activities in 
cells and revealed subsequences that bound strongly to TFs in vivo. It has been well 
accepted that DHSs and TFs binding clusters are enriched with matches to 
biochemically obtained TF motifs, and that they overlap with in silico predicted clusters 
called based on TF motif matches only222,223. However, studies in our lab have shown 
that only ~ 30% of TF binding clusters could be predicted based on monomeric TF 
binding models222, suggesting that other unknown determinants played more important 
roles in TF binding to DNA in vivo. In order to test if ATI can improve the prediction, 
we developed a predictor based on the enrichment rank of all 10-mers in ATI data. The 
results revealed that more than 70% of the DHSs could be predicted by the 10-mers 
derived solely from ATI data (Figure 4.5c; 10% expected by random, p < 3.2 × 10-226; 
winflat209), indicating that ATI derived 10-mer enrichment more accurately represented 
TF activity as well as chromatin accessibility in cells compared to any other presently 
available information. In the analysis of genome-wide DHSs prediction, the ATI data 
was nearly as effective as using 10-mers from the DHSs themselves (Figure 4.5d), 
indicating that the it contains substantial fraction of the motif information included in 
the DHSs, despite the fact that the DHSs are expected to contain additional motif 
features that relate to their functionality in gene regulation and not to their open 
chromatin status. For example, de novo motif discovery analysis of the DHSs in ES 
cells detected many motifs that were different from the ones detected in ATI, including 
one motif similar to that of Znf-143 (Figure 4.5e); this motif has been reported to 
contribute to interactions between promoters and distal regulatory elements224.  
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Figure 4.5 See next page for caption 
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Figure 4.5 Correlation of the DHS data and ATI results from mouse ES cells 
a) The ATI-enriched 10-mers in ES cells are also enriched in DHSs from ES cells. In the dot plot, the rows indicate 3,907 most 
significant DHS sites and flanked genomic sequences from in mouse ES cells; the length of each DHS site together with flanking 
regions is 10 kb. In each row, red dots indicate the two boundaries of the DHS region; blue dots indicate the positions of the top 2% 
ATI-enriched 10-mers. The graph on top shows the average of scores for each 10-mer at each position across the rows. 
b) Comparison of 10-mers in ATI data and DHS regions from mouse ES cells. X-axis indicates the log2 fold change of 10-mer 
counts in DHSs compared with non-DHS regions; y-axis indicates log2 fold change of 10-mer counts in ATI enriched DNA pool 
(Cycle 4) compared with original pool (Cycle 0). Colored dots represent 10-mers that are similar to the motifs detected in the ATI 
assay; black dots indicate the 10-mers that are not similar to any motifs. One 10-mer sequence (“CGGCGGCGGC”) is shown as an 
example of repetitive CG rich sequences which displays high enrichment in DHSs but no enrichment in ATI. 
c) Prediction of ES cells DHS regions based on the ATI result. DHSs were sorted by position of the prediction call (yellow line). 
Black horizontal lines separate accurate DHS calls (in the middle of the plot) from calls >500 bp off the known DHS center, which is 
located at the x-axis position 0 in all DHS sites. The fraction of predictions within ±500 bp of the center (72.4%), and the 
corresponding p value (Winflat) for the null model in which position calls are randomly distributed are indicated.  
d) Genome-wide predictions of the ES cell DHS regions using 10-mer data from the ATI assay and the DHSs themselves are shown. 
The black line represents prediction based on the DHS data (details are included in the “Meterials and Methods” section), and the 
red line represent prediction based on the ATI data. AUC means the area under the curve, and indicates the accuracy and sensitivity 
of the method.  
e) The top ten motifs detected with the lowest E values in DHS regions from ES cells are shown.  
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4.3 STUDY III: THE ATI ASSAY USING NUCLEOSOMAL DNA 
 
4.3.1 Reconstitution of nucleosomes with DNA ligands 
 
Although the ATI technology is quite powerful to determine the most active 
TFs for specific cell identity, it is not so efficient to detect the pioneer TFs with high 
binding affinity with nucleosomal DNA to initiate chromatin structural changes at 
specific loci. In order to determine the pioneer TFs in different types of cells, we 
modified our ATI assay by using nucleosomal DNA instead of naked DNA to incubate 
with the nuclear extract from different cell types.    
The nucleosomes were reconstituted as described previously212 using the histone 
octamers tagged with SBP and 147 bp dsDNA with 101 random bases in the middle. 
Subsequently the reconstitution mix was diluted to a salt concentration of 140 mM 
representing the physiological condition, a small aliquot was removed for EMSA 
experiment, and the remaining nucleosomes as well as the histones were immobilized 
by addition of streptavidin magnetic beads. The free DNA not bound by the histones 
was then washed away.  
The EMSA result confirmed that well-organized nucleosomes were 
reconstituted that shifted the bound DNA fragments to around 400 bp DNA marker in 
the gel. The free DNA migrated at the expected 150-bp position (Figure 4.6). 
Quantitative analysis of the EMSA result further revealed that more than 50% of the 
DNA ligands were assembled into nucleosomes. 
 
 
Figure 4.6 Reconstitution of nucleosomes with 147 bp dsDNA 
The EMSA result shows the reconstituted nucleosomes. The free dsDNA is shifted at approx. 150 bp, and the reconstituted 
nucleosomes are shifted to 400-bp position.   
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4.3.2 ATI assay with nucleosomal DNA determines pioneer TFs 
 
In order to determine the TFs that can compete with histones to bind DNA with 
high affinity, we incubated the reconstituted nucleosomes with the nuclear extract from 
mouse ES cells and liver tissue, and then collected the DNA disassembled from the 
nucleosomes (Figure 4.7a, “supernatant”) and nucleosomal DNA still bound to the 
nuclear proteins by means of EMSA (Figure 4.7a, “EMSA shifted”). The DNA ligands 
collected were amplified and the whole process was repeated for two more cycles.  
De novo motif analysis of both types of DNA libraries based on Autoseed 
program detected several motifs, some of which were not even detected in the standard 
ATI assay by using the pure DNA, implying that the TFs bound to these motifs play 
“pioneer” roles in determining the cell fate. For instance, the bHLH tetrameric and 
HOMEO-domain binding motifs were detected with high enrichment in ES cells and 
liver in both “supernatant” and “EMSA shifted” conditions, but they were not detected 
in the standard ATI assay. Moreover, in the ES cells, we also detected the binding motif 
for heterodimers formed by POU and SOX families TFs under both conditions. In 
addition, we found motifs that were also detected in the same tissue or cell samples in 
the standard ATI assay, for example, the bZIP and ETS motifs in ES cells, and the 
CEBP and NRF1 motifs in the liver.  
 
 
Figure 4.7 ATI assay using nucleosomal DNA determines pioneer TFs 
a) Schematic of the ATI assay with nucleosomal DNA. ATP supplemented provides energy to dissociate the nucleosomes; PEG is 
used to concentrate the proteins and DNA by decreasing the volume of reaction.  
b) Sequence logos and the corresponding TF families identified by de novo motif discovery from supernatant and EMSA shifted 
fractions from  ES cells and liver tissue. The names of the TFs are based on the identified motifs. Motifs which cannot be determined 
based on the current database are marked as “Unknown”. 
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5 DISCUSSIONS 
 
5.1 LIMITED SETS OF TFs ARE HIGHLY ACTIVE IN SPEICIFIC CELL 
IDENTITY 
 
Through measurement of the DNA-binding activities of all TFs in different cell 
or tissue types, the ATI assay indicates that limited sets of TFs are highly active in 
specific cell identity.   
As one of the most important proteins involved in gene regulation, the TFs play 
dominant roles in determining specific cell identity. Nowadays, there exist a number of 
sophisticated technologies that can be applied to study various aspects of TFs. For 
example, as has been mentioned before, in vitro techniques such as the SELEX are 
applicable in determining the binding specificities of different TFs; moreover, the 
SELEX assay can also be utilized to study the kinetics of TF binding. The in vivo 
technique ChIP is applicable in detecting individual binding events of TFs as well as 
other types of proteins in the genome, which directly relates to transcriptional 
regulation controlling particular cell identity.  
The strategy of the ATI technique is quite similar with that used in proteomics. 
The proteomics technology is applied to measure abundance of proteins based on 
quantification of unique peptides (the fingerprints) for all the proteins. Similarly, the 
ATI technique is applied to massively measure the total binding activities of different 
TFs or TF families in the cell nucleus based on the fingerprints- the specific binding 
motifs of different TFs or TF families.  
Differing from techniques such as SELEX and PBM based assays which are 
utilized to determine TF binding specificity in vitro, the ATI assay measures the 
binding activity of TFs/TF families that exist in the cell nucleus based on the 
enrichment of their binding motifs. The word ‘activity’ is used here in the same sense as 
in enzymology, where activity represents total enzyme activity (specific activity × 
molar amount), thus the binding activity of TFs measured in the ATI assay is dependent 
not only on the abundance, but also the specific binding activity of the TFs. The results 
obtained from the ATI assay are unique and more useful than from other techniques 
such as RNA-seq or proteomics, because compared with expression levels, the binding 
activity of TFs is more directly related to the functionality of TFs. Additionally, the 
influence of post-translational modifications of TFs on their DNA binding activity 
cannot be assessed solely from their expression levels. With the ATI method, we are 
now finally able to determine the most active TFs in different cell types which was 
hitherto impossible to achieve with other high-throughput technologies such as RNA-
seq.  
In addition to massively measuring the binding activities of different TFs in the 
cell nucleus, the ATI assay is also quite useful to study the dynamic changes of TFs’ 
binding activities under perturbations. For instance, the ATI assay can been applied to 
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study the TF binding activity changes during differentiation from the ES cells to 
different lineages, resulting in the identification of lineage specific TFs.  
The ATI result suggests that a small number of TFs with the highest DNA 
binding activities in a cell play a major role in setting its overall gene regulatory 
architecture. On the other hand, based on the ChIP-seq analyses, it has been proven that 
plenty of TFs actually bind open chromatin regions in the same cell identity71,225. These 
observations are consistent with a model where TFs that are strongly active in DNA 
binding set up the overall chromatin landscape of the genome, and the binding of TFs 
with weaker DNA binding activity is conditional on this chromatin landscape. This 
gene regulatory model is quite hierarchical, and is consistent with the hierarchical gene 
expression patterns commonly observed in analyses of real biological systems. In 
addition, this model also provides a simple combinatorial gene regulation system. If the 
TF that has strong DNA-binding activity lacks a strong transactivation or repression 
domain, it will require a partner that has such a domain. This cooperating factor may 
not, in turn, be able to bind DNA strongly to open chromatin alone, and therefore will 
require the strong DNA binder. It should be noted that different types of activation 
domains can also contribute to such combinatorial regulation, increasing the number of 
cooperation partners to three or more. 
Admittedly, there are several weak points of the ATI technique. First, the ATI 
assay failed to detect the DNA-dependent cooperative binding of multiple TFs, which is 
frequently detected in vivo. The reason may be that in living cells the proteins in the 
nucleus are more concentrated than the proteins extracted from the cells; moreover, it 
has been stated that different kinds of biomolecules such as the transcriptional 
coactivators226 and the RNA-binding proteins227,228 are more concentrated at specific 
regions due to liquid-liquid phase separation of the proteins, implying the same effect 
for TFs. In addition, the ATI assay is not so sensitive to detect the pioneer TFs because 
for many pioneer TFs such as FOXA1, the expression level is not high enough under 
normal physiological conditions to be detected in ATI, otherwise lots of condensed 
chromatin regions will be open owing to overexpression of such pioneer TFs, leading to 
diseases such as cancer. It is plausible that during transition of cell lineages in normal 
physiological conditions, the pioneer TFs are temporarily expressed to open particular 
loci in the genome, after which they will be down-regulated.  
 
 
5.2 CORRELATION BETWEEN BINDING ACTIVITY OF TFs AND 
CHROMATIN ACCESSIBILITY 
 
Analyses of the ATI data and the DHS regions from the same cell or tissue 
types indicate that the binding activity of TFs and chromatin accessibility in the same 
cell identity are closely correlated, meaning that much of the nucleosome-competing 
activity in cells is due to the TFs present in such a high abundance relative to their Kd 
values in the nucleus that they can effectively and specifically compete against 
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nucleosome binding. Based on the ATI data, we are also able to predict positions of 
open chromatin in mouse ES cells far more accurately than what has previously been 
possible, indicating that the knowledge of TF DNA-binding activity levels is a major 
unknown factor that hindered previous computational predictions of regulatory 
elements. Furthermore, these results suggest that strongly active TFs have a major role 
in setting up the overall chromatin landscape of cells. However, our results cannot be 
interpreted to mean that open chromatin would result exclusively from the action of TFs 
with strong binding activity, or that those strongly bound TFs would be sufficient to 
open closed chromatin states characterized by presence of HP1, histone H1 or 
repressive chromatin modifications229. It is well known that some TFs can directly or 
indirectly recruit enzymes that remodel or modify nucleosomes to generate open 
chromatin and/or de-repress closed chromatin states230,231. It should also be noted that 
quite a few binding sites for less active TFs, or site(s) for cooperatively bound TFs can 
also be bound with sufficient energy to dissociate nucleosomes. Through these 
mechanisms a subset of genomic loci will become accessible, but they are unlikely to 
be the dominant way to open chromatin, as if that was the case, the de novo motif 
mining of the DHS regions would be able to detect the corresponding motifs for those 
cooperative or weak DNA binders. 
Moreover, as DHSs represent gene regulatory elements, they are expected to be 
enriched with not only motifs that contribute to opening of the chromatin, but also 
sequences that are responsible for downstream activities such as transactivation or 
recruitment of RNA polymerase II. Consistently, de novo motif discovery analysis of 
DHSs revealed some motifs that were not enriched by ATI. These included a motif 
similar to that of Znf-143 (Figure 4.5e). On the other hand, because the nucleosomes 
possess weak DNA binding specificity, they also contribute to the accessibility of the 
chromatin genome-wide. However, the influence caused by nucleosome binding 
preference has nothing to do with the cell fate, as it is the same for all cell identities 
with the same genetic background.  
In summary, the close correlation between ATI and DHS data verify that the 
TFs found using ATI are most active and important for the specific cell identity, and 
greatly contribute to genome accessibility in cells. The study of chromatin accessibility 
is still at the primary stage, as we mostly focus on the locations of the accessible 
regions and the sequence features of different DHS sites. Some effort should also be put 
on the classification and functionality of different DHS sites, and the correlation 
between each DHS site and epigenetic states at the adjacent regions.   
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5.3 PIONEER FACTORS WITH HIGH BINDING ACTIVITY WITH 
NUCLEOSOMES 
 
By incubating nuclear extract from cells with nucleosomal DNA in the ATI 
assay, we detected TFs with the highest binding activity with nucleosomes, including 
some TFs that were not detected in the standard ATI assay. These detected TFs are 
regarded as “pioneer” TFs. It is noteworthy that the biochemical activity–based 
identification of pioneer TFs in this thesis is related, but not identical, to the classical 
concept of “pioneer” TFs, which is based on their functionality that they can access 
their target sequences in compacted chromatin and facilitate opening those regions232. 
Take the TF JDP2 as an example, it has been shown that JDP2 can bind the 
nucleosomes directly but promote the assembly of chromatin afterwards133.  
The pioneer TFs detected in the assay can be further divided into two groups 
based on their binding activity with the naked DNA. TFs including bZIP and ETS 
family TFs in ES cells, NRF1 and CEBP family TFs in the liver have significantly high 
binding activity with both the naked DNA and the nucleosomes; the motifs for these 
TFs are only detected in the “supernatant” (Figure 4.7), suggesting that their abilities to 
compete against the nucleosome are mainly due to the mass action rather than 
interacting with nucleosomes. Motifs for TFs such as those from SOX and HOMEO-
BOX families can only be detected by using the nucleosomal DNA (Figure 4.7b), 
indicating that the corresponding TFs may have higher binding activity with the 
nucleosomes than the naked DNA. The reason why these TFs can bind nucleosomal 
DNA with higher affinity is not clear, partially due to the contact between the histone 
residues and the TFs, or the conformational change of the DNA.  
In addition, it is obvious that motifs detected in the “supernatant” are related to 
dissociation of the nucleosomes, indicating the roles of their corresponding TFs in 
opening up condensed chromatin. However, motifs detected in the “EMSA shifted” 
component may be related to either condensation or opening of the chromatin, which is 
highly dependent on other recruited cofactors. In cases where motifs are detected in 
both “supernatant” and “EMSA shifted” components, for example the cooperative 
binding motif of POU and SOX family TFs detected in the ES cells, the contribution of 
their binding is also dependent on the cofactors they recruit at specific genomic loci.  
The pioneer TFs are considered as the dominant factors to initiate changes of 
chromatin accessibility during cell fate transition, but none of their motifs were detected 
by the de novo motif discovery analysis of DHSs, indicating that the pioneer TFs are 
only responsible for opening a small subset of DHS regions in the genome. It is also 
possible that some pioneer TFs are activated temporarily for specific cell identity and 
then become inactive at a later time point, hence the binding activity of pioneer TFs at 
an earlier time cannot be reflected by the chromatin accessibility at a later time point. In 
order to identify those temporarily activated pioneer TFs, it is necessary to capture the 
specific states when the pioneer TFs are activated.  
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6 CONCLUSIONS AND PROSPECTS 
 
All studies included in this thesis have greatly enhanced our understanding of 
how different types of TFs contribute to gene expression in specific cell types.  
Although most TFs are expressed in each cell type, only a small subset of them 
plays a dominant role in determining specific cell fate. These dominant TFs, including 
both general TFs which are ubiquitously active in all cell types and specific TFs which 
are activated only in specific cell lineages, are responsible for setting up the core 
transcriptional regulatory network and regulate gene expression by interacting with 
other less active TFs and cofactors, leading to the hierarchical transcriptional regulatory 
network. With the development of the ATI technology, we are able to decipher the 
dominant TFs based on their DNA-binding activities. Moreover, because the TFs are so 
important for the cell fate, variation of their binding activities is highly correlated with 
transition of cell identities, which frequently occurs during many dynamic processes 
such as development and tumorigenesis. By means of the ATI assay, we are now able 
to massively measure the activity changes of all TFs in parallel and identify the crucial 
TFs with significant DNA-binding activity changes, which can hardly be achieved by 
other high-throughput technologies. 
In addition, the thesis also demonstrates that the cooperative binding activity of 
TFs is a major determinant of chromatin accessibility for specific cell identity. Based on 
the ATI result, we can predict the positions of open chromatin in mouse ES cells more 
accurately than any method applied before, indicating that TFs, especially the strongest 
ones, play dominant roles in determining the chromatin landscape of cells in 
mammalian species. Admittedly, other factors such as the binding specificity of 
nucleosomes and the epigenetic modifications also contribute to the chromatin 
landscape. The nucleosome binding specificity determines for example the starting and 
ending points of transcription units to reduce inefficient transcription. The epigenetic 
modifications could affect the chromatin accessibility by recruiting chromatin 
remodelers or influencing TF binding at those sites. Moreover, it is stated in this thesis 
that the dominant TFs identified in specific cell identity through the ATI technology are 
regarded as the key factors which can be introduced to convert the cell fate to that 
particular cell type, indicating that the ATI technique has great potential in the field of 
regenerative medicine.  
Apart from determining the strongest DNA binders, this thesis also includes 
studies of nuclear proteins and DNA interactions in the context of nucleosomes, which 
is more similar with the real biological system. Through this new method, we are able 
to identify TFs that have significantly high binding specificity and affinity with the 
nucleosomal DNA. Some of these TFs have also been detected in the normal ATI 
assay, indicating that they play important roles in both transition and maintenance of the 
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particular cell fate (such as POU family TF in ES cells); other TFs can only be detected 
in the modified ATI assay using nucleosomal DNA, implying their specific roles in 
interacting with nucleosomes in the genome during the transition of the cell fate. 
In order to measure the DNA-binding activity of cellular proteins with higher 
accuracy, the ATI assay should be optimized to reduce the background. For example, 
capillary electrophoresis could possibly be applied to study the protein-DNA 
interactions instead of the gel-based electrophoresis system. Besides, this massively 
parallel protein activity assay could also be applied to study the TF activity in single 
cells. This is quite promising as it can provide us with crucial information to understand 
the mechanism of cell fate determination in the most desired fields such as the early 
embryonic development of animals and the early stage of cancer development. 
In conclusion, this thesis has introduced a novel technology to massively 
measure DNA-binding activity of all TFs in different types of cells, which is most 
important for us to understand the mechanism of establishment of global chromatin 
landscape as well as gene regulation. Based on the results, the thesis concludes that the 
cell identity is mainly determined by a small set of TFs with the dominant DNA-
binding activity in the nucleus. The dominant TFs are responsible for establishing the 
kernel of the hierarchical transcriptional regulatory network and interacting with other 
less active TFs and cofactors to execute specific transcriptome profiles for particular 
cell identity.  
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